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Abstract
Intracellular bacteria pose a unique set of challenges for the immune system. Many have evolved highly
specialized virulence factors to evade intracellular detection and created a replicative niche. Coxiella burnetii
is a zoonotic intracellular pathogen capable of causing severe acute and chronic Q fever in humans. C. burnetii
grows in the lysosome and persists in cells for more than 10 days. Since C. burnetii can replicate inside cells
for a prolonged period, we hypothesized that C. burnetii evolved multiple mechanisms to subvert innate
immune detection. To test this hypothesis, we tested the ability of the C. burnetii Nine Mile Phase II clone 4/
RSA439 strain to activate innate immune responses in restrictive C57BL/6 bone marrow-derived
macrophages, specifically: detection by surface and cytosolic immune sensors; activation of the
inflammasome; and production of Type I interferon. We found C. burnetii does not robustly stimulate
cytosolic sensors, activate the inflammasome, nor induce robust levels of Type I interferon. These pathways do
not play a significant role in mediating cell-intrinsic control of bacterial replication. We found TLR detection,
specifically TLR2 and TLR4, primarily mediates innate immune detection and restriction of C. burnetii in
C57BL/6 macrophages. We further implicated both TLR adaptors MYD88 and TRIF in this response.
Building upon these findings, we demonstrated soluble TNF induced by TLR signaling plays a major role in
the cell-intrinsic restriction of C. burnetii. We further examined TNF-dependent mechanisms of restriction:
cell death, reactive nitrogen (RNS) and reactive oxygen (ROS) species, and guanylate binding proteins
(GBPs). We found cell death is not induced in macrophages. Although expression of GBPs are induced upon
C. burnetii infection, we ruled out five GBPs as mediators of bacterial restriction. Finally, we found RNS is
induced by C. burnetii in a TNF-dependent manner, and ROS is also induced and plays a role in the cell-
intrinsic control of C. burnetii replication. Together, these studies demonstrate that the C. burnetii Nine Mile
phase II strain is able to evade many arms of the innate immune system in C57BL/6 macrophages and
implicated a specific molecule, TNF, in mediating the cell-intrinsic control of this poorly understood
bacterium.
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ABSTRACT 
 
THE INNATE IMMUNE RESPONSE TO COXIELLA BURNETII 
 
William P. Bradley 
Sunny Shin 
Intracellular bacteria pose a unique set of challenges for the immune system. Many have 
evolved highly specialized virulence factors to evade intracellular detection and created 
a replicative niche. Coxiella burnetii is a zoonotic intracellular pathogen capable of 
causing severe acute and chronic Q fever in humans. C. burnetii grows in the lysosome 
and persists in cells for more than 10 days. Since C. burnetii can replicate inside cells for 
a prolonged period, we hypothesized that C. burnetii evolved multiple mechanisms to 
subvert innate immune detection. To test this hypothesis, we tested the ability of the C. 
burnetii Nine Mile Phase II clone 4/RSA439 strain to activate innate immune responses 
in restrictive C57BL/6 bone marrow-derived macrophages, specifically: detection by 
surface and cytosolic immune sensors; activation of the inflammasome; and production 
of Type I interferon. We found C. burnetii does not robustly stimulate cytosolic sensors, 
activate the inflammasome, nor induce robust levels of Type I interferon. These 
pathways do not play a significant role in mediating cell-intrinsic control of bacterial 
replication. We found TLR detection, specifically TLR2 and TLR4, primarily mediates 
innate immune detection and restriction of C. burnetii in C57BL/6 macrophages. We 
further implicated both TLR adaptors MYD88 and TRIF in this response. Building upon 
these findings, we demonstrated soluble TNF induced by TLR signaling plays a major 
role in the cell-intrinsic restriction of C. burnetii. We further examined TNF-dependent 
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mechanisms of restriction: cell death, reactive nitrogen (RNS) and reactive oxygen 
(ROS) species, and guanylate binding proteins (GBPs). We found cell death is not 
induced in macrophages. Although expression of GBPs are induced upon C. burnetii 
infection, we ruled out five GBPs as mediators of bacterial restriction. Finally, we found 
RNS is induced by C. burnetii in a TNF-dependent manner, and ROS is also induced 
and plays a role in the cell-intrinsic control of C. burnetii replication. Together, these 
studies demonstrate that the C. burnetii Nine Mile phase II strain is able to evade many 
arms of the innate immune system in C57BL/6 macrophages and implicated a specific 
molecule, TNF, in mediating the cell-intrinsic control of this poorly understood bacterium. 
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Introduction: Immune Response to Coxiella burnetii 
 
William P. Bradley 
 
Department of Microbiology, University of Pennsylvania, Philadelphia, PA, 19104, USA 
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General Introduction 
    Successful protection of hosts from pathogenic bacteria, viruses, parasites, and fungi 
involves the activation of complex immune networks that are also tightly regulated to 
prevent damage to the host. Multicellular organisms have evolved a diverse set of innate 
immune responses to prevent infection and establish long-lasting immunity. The 
successful clearance of a pathogen is first initiated by a series of sensor molecules that 
date back to single organisms and are present in all eukaryotes. These sensors, termed 
Pattern Recognition Receptors (PRRs), aid host organisms in distinguishing between 
pathogenic and non-pathogenic bacteria, while at the same time limiting the potential of 
recognizing self-associated molecules (Janeway and Medzhitov, 2002; Medzhitov, 2007; 
Vance et al., 2009). Intracellular bacteria pose a unique set of challenges for the immune 
system. Living inside the host cell shields them from recognition by complement, 
antibodies, and circulating immune cells. Many of these intracellular bacteria have 
evolved strategies to hijack host machinery to both prevent detection and establish a 
replicative niche.  
    Coxiella burnetii, the causative agent of Q (query) fever, is a poorly understood gram-
positive intracellular bacteria. It is the only known bacteria to inhabit and replicate in the 
lysosome, an organelle often thought of to be the dead end of a bacteria’s life cycle 
(Voth and Heinzen, 2007). Q fever can cause acute and chronic infections and is 
transmitted via an aerosol route with alveolar macrophages as the primary cell target 
(Raoult et al., 2005). Remarkably, as few as one bacterium can cause productive 
infection (Moos and Hackstadt, 1987). Once internalized by host cells, C. burnetii uses a 
specialized secretion system, termed the Type IV secretion system (T4SS), to inject 
effector proteins that are thought to target host cell machinery to aid in the maturation 
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and expansion of its unique parasitophorous vacuole (PV) (Heinzen et al., 1996; 
Seshadri et al., 2003; van Schaik et al., 2013). Inside the cell, C. burnetii is able to 
survive and replicate for days and form a vacuole that occupies the majority of the host 
cell cytosol (van Schaik et al., 2013). Systemically, C. burnetii does not induce robust 
neutrophil recruitment and requires an adaptive immune response for clearance (Elliott 
et al., 2013). In some instances, C. burnetii is able to overcome innate and adaptive 
immune barriers and establish chronic infection, spreading to the heart and liver to cause 
severe pathology in the host organism (Maurin and Raoult, 1999; Raoult et al., 2005). 
Despite its relatively early discovery in 1937, little is known about the innate immune 
response to C. burnetii (Derrick, 1983; Kovácová and Kazár, 2002). Due to the potential 
to cause severe disease in humans, its global presence (Marrie, 2010), and the potential 
to be used as a bioterrorism agent (Hackstadt, 1996), better understanding of the host 
immune response to C. burnetii and its evasion strategies are of high importance to limit 
the health and economic burdens of this disease. 
 
Innate Immune Detection of Pathogens 
Surface sensors 
    In host defense against pathogens, pattern recognition receptors that reside at the cell 
surface serve as the first line of detection to distinguish pathogenic and non-pathogenic 
bacteria. All eukaryotic organisms possess one or more of these receptors, which sense 
a broad array of pathogen-specific molecules. In vertebrate animals, surface and 
endosomal Toll-like receptors (TLRs) recognize molecular patterns, many of which are 
unique to bacteria, viruses, eukaryotic parasites, and fungi. Mice encode twelve 
functional TLRs, while humans encode ten. TLRs 1, 2, 4, 5, 6, 10 are exist on the cell 
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surface, while TLRs 3, 7, 8, and 9 are present in endosomes (Akira, 2003). These 
receptors use their N-terminal extracellular leucine-rich repeat domains to bind 
conserved microbial products, termed Pathogen-Associated Molecular Patterns 
(PAMPs) (Janeway and Medzhitov, 2002), or host stress signals, termed Danger-
Associated Molecular Patterns (DAMPs). Upon recognition of foreign or host danger 
signals, TLRs undergo a conformational change in their C-terminal Toll/interleukin-1 
receptor (TIR) domain. This conformational change activates cytosolic adaptor proteins 
which in turn activate signaling cascades to initiate anti-microbial responses (Akira, 
2003). Monocytes, macrophages, and dendritic cells (DCs) constitutively express all 
TLRs while neutrophils, B cells, T cells and epithelial cells express only a few (Kumar et 
al., 2009). Each TLR has a distinct repertoire of ligands. The first characterized TLR, 
TLR4, was found to recognize lipopolysaccharide (LPS), a component of the gram-
negative bacterial cell wall, but has been found to also recognize host heat shock 
protein, glycoproteins, and the fusion protein of respiratory syncytial virus (RSV) (Kawai 
and Akira, 2009). TLR2 recognizes both gram-negative and gram-positive bacterial-
associated lipoproteins, peptidoglycan, and lipoteichoic acid (LTA), TLR2 can also 
dimerize with TLR1 or TLR6, providing an extra layer of ligand specificity. TLRs 3, 7, 8, 
and 9 all recognize foreign nucleic acids such as double-stranded RNA and DNA. Many 
TLR ligands, however, have yet to be discovered and are of great interest in both 
infectious and autoimmune diseases (Akira, 2003; Kumar et al., 2009).  
    All TLRs, except TLR3, signal through the adaptor MyD88, which in turn activates 
IRAK4, which then activates the NF-κB pathway and the mitogen-activated protein 
kinases (MAPKs) p38 and JNK. Activation of these pathways results in the transcription 
and translation of several pro-inflammatory cytokines, including TNF, IL-6, IL-12, and the 
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pro-forms of IL-1α and IL-1β. The adaptor Trif is activated by TLR3 and TLR4 and 
results in the phosphorylation of interferon regulatory factors (IRFs). IRF3 and IRF7 
induce the production of type 1 interferons (IFNs) IFNα and IFNβ. TLR4 can also signal 
through Trif to activate the NF-κB pathway and induce pro-inflammatory cytokine 
production (Akira, 2003). 
    The specific TLRs triggered dictate the downstream cell-extrinsic and cell-intrinsic 
responses. The ability of surface sensors to detect diverse sets of ligands and induce a 
range of signaling cascades provide cells with finely tuned outcomes to a broad range of 
pathogenic and host-derived stressors. TLR sensing has been implicated in the 
intracellular and systemic restriction of intracellular pathogens M. tuberculosis and L. 
pneumophila (Abel et al., 2002; Akamine et al., 2005; Reiling et al., 2002; Spörri et al., 
2006; Zhang et al., 2013). 
 
Cytosolic sensing 
    In addition to surface sensors, many cell types possess an additional line of defense 
in the form of cytosolic sensors. Since many TLR ligands are expressed by both 
pathogenic and non-pathogenic or commensal microbes, eukaryotic cells have evolved 
strategies to respond to a phenomenon unique to many pathogenic microbes – cytosolic 
access.  
    Most viruses access the cytosol during their natural replication cycle. Some 
pathogenic bacteria and parasites access the host cytosol either through the production 
of pore-forming toxins, such as Listeriolysin O expressed by the gram-positive bacterium 
Listeria monocytogenes (Hamon et al., 2012), or through the use of specialized secretion 
systems, such as the Type III secretion systems (T3SS) employed by Salmonella 
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enterica and Yersinia spp. and the Type IV secretion systems (T4SS) used by Legionella 
pneumophila and Brucella abortis (Cornelis, 2006; de Figueiredo et al., 2015; Pujol and 
Bliska, 2005; Qiu and Luo, 2013). These multiprotein structures act as molecular 
syringes and inject effector proteins into the host cytosol to hijack host machinery and 
establish a replicative niche (Roy and Mocarski, 2007). While cytosolic access is 
required for these pathogens to establish infection, host cells have co-evolved innate 
immune sensors to respond to this invasion (Franchi et al., 2009; Kawai and Akira, 
2009).  
    Cytosolic sensors respond to a variety of PAMPs. Similar to TLRs, the immunological 
outcome depends on the specific ligand and sensor. Cytosolic sensors induce signal 
transduction cascades analogous to TLRs to produce pro-inflammatory cytokines and 
Type I interferons. Some cytosolic sensors are further capable of inducing formation of a 
multiprotein complex termed the inflammasome, which activates the host enzymes 
caspase-1 and caspase-11 and induces a form of highly inflammatory cell death termed 
pyroptosis (Franchi et al., 2009).  
    One class of cytosolic sensors, nucleotide-binding oligomerization domain (NOD)-like 
receptors (NLRs), contain 16 members that are subdivided into five structural families: 
NLRAs contain an acid-activation domain; NLRBs contain a baculovirus inhibitor of 
apoptosis domain; NLRCs contain a CARD domain; NLRPs contain a pyrin domain; and 
NLRXs contain an unidentified domain. The best characterized NLR family members are 
the NLRC receptors, NOD1 and NOD2, and the inflammasome-inducing NLRP receptors 
(Franchi et al., 2009; Inohara et al., 2005).  
    Like TLRs, different cell types express different sets of NLRs. NOD1 is ubiquitously 
expressed by macrophages, human mononuclear cells, epithelial cells in the airway and 
	  
	   7 
intestine, and dendritic cells, (Chamaillard et al., 2003; Inohara et al., 2005). NOD2 is 
expressed at higher levels in phagocytic cells and Paneth cells of the small intestine 
(Carvalho et al., 2015; Kobayashi et al., 2005). NOD1 and NOD2 both recognize 
bacterial peptidoglycan secreted by bacteria via outer membrane vesicles or through 
their specialized secretion systems. NOD1 has been implicated in the recognition of 
Chlamydophila pneumonia (Shimada et al., 2009), Legionella pneumophila (Berrington 
et al., 2010; Frutuoso et al., 2010; Shin et al., 2008), Klebsiella pneumonia (Regueiro et 
al., 2011), and Pseudomonas aeruginosa (Travassos et al., 2005), while NOD2 
responds to Streptococcus pneumonia (Opitz et al., 2004), L. pneumophila (Berrington 
et al., 2010; Frutuoso et al., 2010; Shin et al., 2008), E. coli (Theivanthiran et al., 2012), 
C. pneumonia (Shimada et al., 2009), and M. tuberculosis (Ferwerda et al., 2005). 
    A second set of cytosolic sensors, retinoic-acid-inducible protein 1 (RIG-I)-like sensors 
(RLRs) and other nucleic acid sensors, have been established in anti-viral responses, 
but have recently been shown to respond to bacterial nucleic acids to induce Type I 
interferon production (Kawai and Akira, 2009; Yoneyama and Fujita, 2007). Notable 
examples in the context of bacterial infections include: DNA-dependent activator of IFN-
regulatory factors (DAI), which response to S. pneumonia (Parker et al., 2011); leucine-
rich repeat (in FLII) interacting protein 1, LRRFIP1, which responds to L. monocytogenes 
(Yang et al., 2010); RIG-I, MDA5, and RNA Pol III, which respond to L. pneumophila 
(Chiu et al., 2009; Monroe et al., 2009); and the absent in melanoma 2 (AIM2) 
inflammasome, which responds to F. tularensis and L. monocytogenes (Fernandes-
Alnemri et al., 2010; Rathinam et al., 2010).  
    The combined action of surface and cytosolic sensors provides host organisms with a 
broad and rapid barrier to many pathogens. Some pathogens, however, have evolved 
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strategies to evade one or more of these barriers and as a result, establish productive 
infection. 
 
Outcomes of Innate Immune Sensing 
     The specific outcome of surface and cytosolic detection depends on the pathogen 
and its ability to activate these sensors. The consequences of innate immune activation 
can be grouped into two categories: cell-extrinsic and cell-intrinsic. Cell-extrinsic 
responses rely on cytokine, chemokine, and interferon signaling from the infected cell to 
neighboring cells in order to mount a multicellular immune response. Cell-intrinsic 
responses can occur via signaling from the sensors themselves or via the action of a 
secondary molecule such as pro-inflammatory cytokines. 
 
Cell Extrinsic Immune Responses 
Innate Immune Cell Activation and Recruitment 
    Upon stimulation of surface and cytosolic sensors, signaling cascades are activated to 
produce and secrete pro-inflammatory cytokines (e.g. TNF, IL-6, IL-12, IL-1α, and IL-1β), 
chemokines, and Type I interferons (Akira, 2003; Kawai and Akira, 2009). Pro-
inflammatory cytokines and chemokines can activate and/or recruit other innate and 
adaptive immune cells to the site of infection. Type I interferons activate a set of immune 
genes that were classically thought to primarily induce an anti-viral response. Recently, 
Type I interferons have been implicated in host responses to bacterial infection, but the 
mechanisms underlying how they restrict bacterial replication remain poorly understood 
(Coers et al., 2007; Manzanillo et al., 2012; Monroe et al., 2010).  
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Activation of Humoral Immunity 
    B cells provide another arm of the immune response and are activated by cytokines 
released by stimulated CD4+ T cells or by TLRs expressed on B cells themselves. 
Studies have shown that antibodies (Abs) mediate protection against pathogens through 
direct bacticidal activity, complement activation, opsonization, cellular activation via Fc or 
complement receptors, and Ab-dependent cytotoxicity. Ab-mediated protection has been 
described in host defense against the intracellular bacteria Mycobacterium tuberculosis 
(Teitelbaum et al., 1998), L. monocytogenes (Edelson et al., 1999), and Ehrlichia 
chaffeensis (Li et al., 2001; Winslow et al., 2000). 
    In addition to direct immune action, specific Ab isotypes have been shown to modulate 
Th1 activation via Fc receptors (FcR). Interaction with these serotypes augments the T 
cell response by inducing rapid pathogen uptake, processing, and presentation of 
pathogen associated antigens. FcR-mediated antibody interactions were implicated in 
the T cell immunity against Chlamydia trachomatis (Moore et al., 2002). 
 
Activation of T cell response 
    The mounting of a T cell response is also mediated by pro-inflammatory cytokines. 
The cytokine IL-12 stimulates a Th1 CD4+ T cell response, which results in the release 
of IFNgamma and TNF. These cytokines released by T cells make infected cells more 
anti-microbial by increasing production of reactive oxygen (ROS) and reactive nitrogen 
(RNS) species inside the infected cell to promote pathogen killing.   
 
Cell-intrinsic immune responses  
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     Detection of pathogens by surface and cytosolic censors can result in a variety of 
cell-intrinsic immune responses to limit intracellular infection. These responses can be 
activated by the sensors themselves or through their induction of pro-inflammatory 
cytokines. 
 
Cell death 
     Programmed cell death is one cell intrinsic mechanism to limit bacterial infection. The 
death of infected cells eliminates the pathogens intracellular niche and, in some 
instances, releases pro-inflammatory molecules to alert neighboring cells. Three classes 
of programmed cell death have been described: apoptosis, pyroptosis, and nectroptosis 
(Ashida et al., 2011; Fink and Cookson, 2005).  
    Apoptosis is a non-inflammatory cell death and has two forms: intrinsic apoptosis 
results when intracellular stressors disrupt the mitochondria membrane, whereas 
extrinsic apoptosis occurs via activation of caspase-8 by death receptors present on the 
cell surface. Both of these apoptotic cascades converge on capsase-3 which in turn 
activates a series of events resulting in DNA fragmentation, membrane blebbing, 
deconstruction of cellular components, and cell death (Elmore, 2007). 
    Necroptosis, or regulated necrosis, occurs as a back up death when the extrinsic, 
capsase-8 apoptotic pathway is blocked. This caspase-independent form of cell death 
occurs through the TNF receptor (TNFR) which signals to TNFR-associated death 
protein TRADD to activate RIP1 kinase, which recruits RIP3 kinase to form the 
necrosome. The formation of the necrosome leads to cell death and the release of cell 
components containing danger associated molecular patterns (DAMPs), such as 
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heatshock protein, ATP, and mitochondrial DNA, which can stimulate the same set of 
PRRs as PAMPs (Pasparakis and Vandenabeele, 2015; Vandenabeele et al., 2010). 
    Pyroptosis is a pro-inflammatory form of cell death that occurs via the activation of the 
inflammasome. Inflammasome activation is a two step process. The first signal occurs 
when TLRs and cytosolic sensors upregulate inflammsome machinery and the pro forms 
of IL-1α and IL-1β. A second signal, such as flagellin or extracellular ATP, binds certain 
cytosolic sensors to activate caspases-1 and -11. Caspase activation then initiates cell 
death and release of pro-inflammatory IL-1 family cytokines (Casson and Shin, 2013; 
Fontana and Vance, 2011; Franchi et al., 2012). 
 
Reactive oxygen and reactive nitrogen species     
Stimulation of surface and cytosolic sensors can also induce the production of reactive 
oxygen species (ROS) and reactive nitrogen (RNS) species. ROS is generated by the 
NADPH phagocytic oxidase (Phox), while RNS is generated by inducible nitric oxide 
synthase (iNOS) (Nathan and Shiloh, 2000). Both complexes are expressed in 
mononuclear (monocytes and macrophages) and polymorphonuclear (neutrophils) 
phagocytes. Neutrophils express more ROS than macrophages, and macrophages 
express more RNS than neutrophils (Nathan and Shiloh, 2000). 
    ROS is generated upon the formation of a multimeric protein complex that is pre-
synthesized in phagocytes. Two membrane-bound proteins, p22phox and gp91phox, 
interact with the cytosolic proteins p40phox, p47phox, and p91phox. Upon activation by 
phagocytosis, the cytosolic components translocate to the phagosome and assemble 
with flavocytochome b558 to form the functional NADPH oxidase complex (Bylund et al., 
2010). Oxygen radicals are formed via electron transfer, which in turn spontaneously 
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generate hydrogen peroxide intermediates. Highly toxic hydroxyl radicals and 
hypochlorous acid are then generated via the Fenton reaction or by cellular 
myeloperoxidase (MPO) (Imlay and Linn, 1988; Imlay, 2008; Tlili et al., 2011). These 
molecules likely target bacterial DNA and can also act as signaling molecules to induce 
pro-inflammatory cytokines and cell death. 
   TNF, IFNγ, and TLR ligands, such as LPS, stimulate the de novo synthesis of iNOS, 
which contains an N-terminal oxygenase and a C-terminal reductase (Vila-del Sol et al., 
2007). iNOS forms homodimers and localizes to the phagosome in an actin dependent 
manner. It produces nitric oxide radicals from the L-arginine substrate (Albakri and 
Stuehr, 1996; Baek et al., 1993; Davis et al., 2007). Nitrogen radicals target a complex 
repertoire of bacterial components including bacterial DNA, proteins, and lipids. Bacterial 
death likely occurs through the disruption of bacterial respiration components (Nathan 
and Shiloh, 2000). 
     Intracellular pathogens have evolved strategies to evade RNS and ROS toxicity. To 
scavenge ROS, some pathogenic bacteria encode superoxide dismutases (SODs), 
catalases, and peroxiredoxins (Prxns) (Chelikani et al., 2004; Gort and Imlay, 1998; 
Parsonage et al., 2005). Low molecular weight thiols and free or residual methionine are 
utilized to scavenge both ROS and RNS (Boschi-Muller et al., 2005; Carmel-Harel and 
Storz, 2000). 
 
Autophagy 
     Autophagy, specifically the subclass termed xenophagy, has been implicated in anti-
bacterial defense. When endosomal trafficking of microbes to terminal lysosomes is 
subverted, autophagy provides a back up mechanism to degrade foreign invaders. In 
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phagocytes, recognition of PAMPs by both surface and cytosolic sensors to induce a 
microbicidal form of autophagy known as xenophagy (Levine et al., 2011).  
 
Guanylate Binding Proteins (GBPs) 
    Recently a family of IFNγ-inducible GTPases termed guanylate binding proteins 
(GBPs) have been implicated in the cell-intrinsic control of intracellular pathogens. 
Humans encode seven GBPs (hGBP1-7), while mice encode eleven (mGBP1-11) 
(Olszewski et al., 2006; Vestal and Jeyaratnam, 2011). GBPs are classically thought to 
be induced by Type I and Type II interferons, but select GBPs have been shown to be 
induced by IL-1α, IL-1β, and TNF (Vestal and Jeyaratnam, 2011). Upregulated GBPs 
are targeted to cellular membranes by isoprenylation, or the addition of a C-15 farnesyl 
or C-20 geranylgeranyl lipid moieties to the cysteine in a conserved C-terminal CaaX 
sequence (Vestal and Jeyaratnam, 2011). Both mice and human GBPs have been 
implicated in the control of intracellular bacteria. hGBP-1 and hGBP-2 inhibit replication 
of Chlamydia spp (Tietzel et al., 2009); mGBP-5 promotes and mGBPs encoded on 
chromosome 3 have been implicated in Salmonella Typhimurium and L. pneumophila 
induced pyroptosis, respectively (Meunier et al., 2014; Pilla et al., 2014). 
 
Bacterial Subversion of Sensing 
    To overcome the wide array of innate immune barriers, pathogenic bacteria have 
evolved many strategies to evade or subvert innate immune detection in order to 
establish infection. These strategies can be grouped into two categories: the alteration or 
deletion of PAMPS, and active inhibition of innate immune signaling via secreted 
bacterial effectors or toxins (Bhavsar et al., 2007). 
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Immune evasion by molecular changes via evolution 
     Some pathogens have altered their PAMPs to be non-stimulatory or antagonistic. 
One such variation occurs in the Lipid A portion of the LPS expressed by gram-negative 
bacteria. TLR4 preferentially recognizes hexa-acylated Lipid A with fatty acid side chains 
between 12-16 carbons in length (Miller et al., 2005; Roy and Mocarski, 2007). Species 
of Legionella and Rhizobium have increased the length of their fatty acid side chains to 
>20 carbons and as a result, are less stimulatory to TLR4 (Schromm et al., 2000). 
Helocobacter pylori, a human pathogen of the stomach, encodes a tetra-acylated Lipid A 
with fatty acid chains ranging from 16-18 carbons, which is not sensed by TLR4 (Moran 
et al., 1997). 
    To avoid detection by flagellin sensors, such as TLR5 and NAIP5, some bacteria 
encode variations in their flagellin or downregulate its expression. Several members of 
the α- and ε- classes of the phylum Proteobacteria phylum, including H. pylori, encode 
mutations in the N-terminus of flagellin, rendering the molecule incapable of activating 
TLR5 (Gewirtz et al., 2004). Other bacteria that invade the mucosal epithelium, such as 
Salmonella enterica serovar Typhimurium and Campylobacter jejuni, regulate expression 
of their flagellin by turning off expression of the stimulatory molecule to successfullly 
colonize the host (Kinsella et al., 1997; Simon and Samuel, 2007). 
    Gram-positive bacteria have also evolved strategies to evade detection. To shield 
their cell wall from TLR2 detection, Streptococcus pneumoniae and Klebsiella 
pneumoniae form a polysaccharide capsule (Benghezal et al., 2007; Geno et al., 2015; 
Regueiro et al., 2011). Distinct structural adaptations in both gram-positive and gram-
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negative bacteria have allowed many species to thwart host recognition and establish 
productive infection. 
 
Use of toxins or effector proteins to evade innate immunity 
    Bacteria also encode virulence factors that target and dampen innate immune 
responses. The gram-positive bacterium Baccillus anthracis encodes a metalloprotease 
toxin that targets and inactivates MAPKs, resulting in apoptosis of macrophages and 
dendritic cells. The induction of apoptosis is thought to prevent signaling from these 
immune cells to other cells, allowing B. anthracis to colonize the host (Collier and Young, 
2003).  
     Some species of gram-negative bacteria encode specialized secretion systems, such 
as the Type III and Type IV secretion systems. These multi-protein complexes act as  
molecular syringes that are thought to form pores in cell surface or endosomal 
membranes and translocate effector proteins that target host machinery (Diepold and 
Armitage, 2015; Trokter et al., 2014). Many of these effector proteins have eukaryotic-
like domains – likely the result of horizontal gene transfer. Effector proteins target 
numerous host processes, including various signaling cascades, vesicular transport, 
gene expression, and cell death pathways . Type III secretion systems are encoded by 
many bacteria, including Yersinia spp. and Salmonella spp, and Type IV secretion 
systems are encoded by several other bacteria, including Legionella spp., Brucella 
abortis, and C. burnetii (Diepold and Armitage, 2015; Trokter et al., 2014). 
 
Coxiella burnetii 
Epidemiology 
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   Coxiella burnetii is a gram-negative, intracellular bacterium that causes Q (query) fever 
in humans. Q fever can manifest as an acute infection with flu-like symptoms or progress 
to a system chronic infection which can lead to endocarditis or hepatitis (Maurin and 
Raoult, 1999; Raoult et al., 2005). Livestock is the primary reservoir for C. burnetii, with 
many outbreaks linked to goats (Raoult et al., 2005; Whelan et al., 2011). The bacteria 
can persist in herds and spread in massive quantities during the livestock birthing 
process, and infection of pregnant livestock often results in stillbirths (Di Domenico et al., 
2014; Raoult et al., 2005). Transmission leads to persistence within herds and puts 
nearby humans at a high risk of exposure. While human-to-human transmission is 
extremely rare, a recent three year outbreak in the Netherlands linked to dairy goat 
farms that resulted in over 4,000 human cases and mass culling of goat herds 
highlighted the potential health and economic burden C. burnetii can cause (Enserink, 
2010; Roest et al., 2011). The only C. burnetii vaccine approved for human use is 
available solely in Australia. While proven effective at protecting non-exposed 
individuals, it can also cause severe adverse reactions in individuals previously exposed 
to C. burnetii (Chiu and Durrheim, 2007). The outbreak potential, limited prophylaxis 
options, and potential use as a bioterrorism agent highlight the need for a better 
understanding of C. burnetii pathogenesis and how the host immune response can 
successfully control this organism. 
    Despite the relatively early discovery of C. burnetii in 1937, knowledge of other 
bacterial pathogens have far outpaced C. burnetii due to its BSL-3 and Select Agent 
designation and history as an obligate intracellular pathogen, with past difficulties with 
cell-free growth (Derrick, 1983; Raoult et al., 2005). The generation of an avirulent BSL-2 
lab strain and the recent development of axenic media has opened doors for a better 
	  
	   17 
molecular understanding of C. burnetii’s pathogenesis (Omsland et al., 2009; 
Vishwanath and Hackstadt, 1988). 
    The primary entry route for C. burnetii in humans is through inhalation into the lung 
and infection of alveolar macrophages (Raoult et al., 2005; van Schaik et al., 2013). 
While it is known that C. burnetii can infect any nucleated cell, it is thought to prefer 
macrophages (Elliott et al., 2013). The incubation time prior to the onset of disease 
symptoms varies from a few days to months, a relatively long period compared to other 
pathogens (Raoult et al., 2005). Acute infection occurs in ~40% of exposed individuals, 
where patients experience flu-like symptoms that can last for days to weeks (Harris et 
al., 2000). Cases of acute infection are largely self-limiting and can be treated with a two 
week regiment of doxycycline (Raoult et al., 2005). 1-5% of acute presentations can 
progress to a more severe chronic infection which can have devastating consequences 
(Tissot-Dupont and Raoult, 2008). In chronically infected individuals, C. burnetii spreads 
to the heart and liver and can cause severe endocharditis or hepatitis, with patients often 
needing heart valve replacement surgery or liver transplants (Tissot-Dupont and Raoult, 
2008). 
 
Coxiella burnetii biology 
    C. burnetii is a gram-negative intracellular bacteria of the phylum Proteobacteria, 
class γ-Proteobacteria, order Legionalles, class Coxiellaceae (Maurin and Raoult, 1999; 
Roux et al., 1997; Stein et al., 1993). C. burnetii’s genome contains ~2.0-2.2 Mb with 
~57.8% AT’s, which is thought to aid in homologous gene transfer of eukaryotic-like 
proteins that aid in its pathogenesis (Raghavan et al., 2008; Seshadri et al., 2003). It is a 
relatively small bacteria with its size ranging from 0.2-0.4 μM wide and 0.4-1 μM long, 
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and it is highly resistant to environmental stressors such as dessication and heat (Raoult 
et al., 2005). Its replication time is estimated at 12-20 hours (Zamboni et al., 2002). 
     C. burnetii has a pleomorphic coccobacilli shape and exists as two morphologically 
distinct cell types. The environmentally stable, non-replicative, small cell variant (SCV) is 
characterized by condensed chromatin and is thought to be the more infectious of the 
two variants (Hackstadt and Williams, 1981). The replicative, large cell variant (LCV) 
develops upon internalization by the host cell or when introduced into nutrient-rich, 
acidified citrate cysteine medium (ACCM) (Coleman et al., 2004; Hackstadt and 
Williams, 1981; Omsland et al., 2013). This morphological shift is marked by alterations 
in the surface protein composition, activation of metabolism pathways, and replication 
(Coleman et al., 2004; 2007). Once the bacteria reaches stationary phase either inside 
the host cell or in axenic media, the bacteria revert back to the small cell variant 
(Coleman et al., 2004; 2007; Omsland et al., 2013). 
     Further variations occur with the bacterium’s lipopolysaccharide. The smooth, virulent 
form (Phase I) contains a highly branched O-chain, containing the unusual sugars 
virenose (6-deoxy-3-C-methyl-D-gulose) and dihydrohydroxystreptose (3-C-
(hydroxymethyl)-L-lyxose (Amano et al., 1987; Moos and Hackstadt, 1987; Toman and 
Kazár, 1991). This branching is thought to aid in the evasion of serum-mediated killing 
(Vishwanath and Hackstadt, 1988). The attenuated and laboratory adapted Nine Mile 
Phase II clone 4/RSA439 strain is the standard lab strain, and was derived from the 
virulent Nine Mile phase I strain via serial lab passages in embryonated eggs. Serial 
passage resulted in the deletion of large chromosomal regions containing open reading 
frames associated with O-chain synthesis, which is thought to account for its attenuated 
virulence in vivo  (Moos and Hackstadt, 1987).  
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Coxiella burnetii inside the host cell  
     C. burnetii is internalized by two mechanisms: active phagocytosis and passive 
binding to leukocyte response integrin (αVβ3 integrin) and CR3 receptor (Boyle and 
Finlay, 2003; Capo et al., 1999; Dellacasagrande et al., 2000). Once internalized, C. 
burnetii traffics down the canonical endosomal pathway, terminating in an acidic, 
lysosome-like compartment (Heinzen et al., 1996; Kinchen and Ravichandran, 2008). 
The C. burnetii-containing vacuole also engages autophagy pathways, and can undergo 
homotypic fusion with other C. burnetii-containing vacuoles (Heinzen et al., 1996; 
Romano et al., 2007). Authophagic engagement is thought to provide the bacteria with 
nutrients and membrane for vacuole expansion (Romano et al., 2007). Unlike Legionella, 
which blocks lysosomal maturation of its vacuole (Isberg et al., 2008), C. burnetii traffics 
to a fully mature phagolysosome containing both early endosomal marker Rab5 and late 
endosomal marker Rab7 (Berón et al., 2002). The mature PV also contains the 
lysosome-associated marker LAMP-1, the lysosomal hydrolase acid phosphatase, and 
cathepsin D (Heinzen et al., 1996; Howe et al., 2010). Upon lysosomal maturation, C. 
burnetii begins to form its intracellular niche, the parasitophorous vacuole, which takes 
~24-48 hours to mature (Heinzen et al., 1996; Howe et al., 2003). Approximately 8 hours 
post internalization, C. burnetii undergoes a morphological switch from the infective 
small cell variant to replicative large cell variant and begins injecting effector proteins into 
the host cell via its Type IV secretion system (Newton et al., 2013). These effectors are 
thought to hijack host cell machinery to enable the acquisition of nutrients and host 
membrane, and prevent host cell death (Coleman et al., 2004; Heinzen et al., 1996; van 
Schaik et al., 2013). C. burnetii continues to replicate in this PV for days, forming a large 
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vacuole that can occupy the majority of the host cell cytosol and can contain upwards of 
100 bacteria per vacuole (Coleman et al., 2004).  
 
Coxiella burnetii’s Type IV Secretion System 
    C. burnetii encodes a Type IV secretion system (T4SS) that delivers bacterial effector 
proteins to the host cytosol (van Schaik et al., 2013). C. burnetii’s T4SS is highly 
homologous to L. pneumophila’s Dot/Icm (defect in organelle trafficking/intracellular 
multiplication) T4SS system (Seshadri et al., 2003). Previous studies that identified many 
of the known C. burnetii T4SS effector proteins utilized L. pneumophila as a surrogate 
for translocation assays to screen or test potential C. burnetii effectors, as its T4SS is 
both genetically and functionally homologous to L. pneumophila’s T4SS (Vogel, 2004; 
Zamboni et al., 2003). To date, over 100 effector proteins have been identified. Many of 
these effectors have eukaryotic domains and are targeted to distinct regions of the cell 
(van Schaik et al., 2013). Since a functional T4SS is necessary for bacterial replication 
(Beare et al., 2011), it is thought that these effector proteins hijack host machinery to aid 
in vacuole formation, nutrient acquisition, alteration of gene expression, and subversion 
of host immune responses. So far, three effectors, AnkG, CaeA, and CaeB, have been 
linked to the inhibition of intrinsic apoptosis (Klingenbeck et al., 2013; Lührmann et al., 
2010), and several effectors have been linked to vacuole formation (Graham et al., 2015; 
Larson et al., 2013; 2015; Newton et al., 2014; Weber et al., 2013).  
 
Host recognition of Coxiella burnetii 
    Unlike L. pneumophila, which evolved to infect single cell amoeba and has not 
acquired virulence factors that specifically interfere with innate or adaptive immunity, 
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successful clearance of C. burnetii requires both innate and adaptive immune 
responses. The activation of innate immune pathways and the downstream adaptive 
response remain poorly understood.  
 
TLR and NLR Sensing 
    Studies on innate immune recognition of C. burnetii have shown differing results 
depending on the bacterial strain or host cell used and have largely focused on TLR2 
and TLR4. One study showed that Phase I C. burnetii productively replicates in human 
dendritic cells without stimulating TLR2 or the maturation of the DCs (Shannon et al., 
2005). Another study demonstrated that C. burnetii Phase II does stimulate TLR2, 
resulting in the secretion of TNF (Zamboni, 2004). In this study, TLR2 was found to play 
a role in inhibiting growth in C57BL/6-background murine bone marrow-derived 
macrophages as Tlr2-/- macrophages showed increased vacuole size and bacterial 
replication (Zamboni et al., 2003). A recent study further demonstrated that TLR2 
signaling relied on heterodimerization with TLR1, while TLR6 deficiency did not result in 
an attenuated immune response in response to infection with the Nine Mile strain 
(Ammerdorffer et al., 2014). It is hypothesized that the highly branched Phase I LPS acts 
as a shield and prevents exposure of TLR2 agonists, which could explain the previously 
described robust Th1 response in mice infected with Phase II, but not Phase I bacteria 
(Roy and Mocarski, 2007; Schromm et al., 2000). 
    The role of TLR4 is still unclear. It was found that TLR4 mediates bacterial uptake of 
Phase I, but not Phase II bacteria (Honstettre et al., 2004). Furthermore, the previous 
study linking TLR2 detection of C. burnetii to production of TNF in mouse macrophages 
demonstrated purified C. burnetii lipid A was a TLR4 antagonist (Zamboni et al., 2004). 
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The same study implicating TLR1-mediated detection of C. burnetii also showed that 
NOD2 plays a role in cytokine production, providing insight into the first potential 
cytosolic sensor activated by C. burnetii (Ammerdorffer et al., 2014). 
 
Neutrophil Recruitment 
    Neutrophil recruitment to the site of infection is a major defense mechanism against a 
variety of lung pathogens, usually occurring around 24 to 48 hours post-infection 
(Balamayooran et al., 2010). It was shown that C. burnetii delays neutrophil recruitment 
for approximately seven days (Elliott et al., 2013). The same research group further 
performed a study indicating that neutrophils are important for clearance, as antibody-
mediated depletion of neutrophils resulted in more severe infection (Elliott et al., 2013). 
The recruitment of neutrophils during C. burnetii infection was found to be independent 
of both CXCL2 and IL-17, two classical neutrophil recruitment molecules (Balamayooran 
et al., 2010; Elliott et al., 2015). 
 
Adaptive Immune Response 
      Successful clearance of C. burnetii requires an adequate adaptive immune 
response. Studies in SCID and nude mice, which lack both T and B cells, are highly 
susceptible to C. burnetii infection (Andoh et al., 2003; Kishimoto et al., 1978). 
Furthermore, immunocompromised individuals, such as patients on immunosuppressive 
treatment, with lymphomas, or pregnant individuals are more likely to develop chronic Q 
fever (Capo and Mege, 2012).  
    Successful control of acute Q fever relies on a systemic T cell response, likely Th1, 
and granuloma formation (Maurin and Raoult, 1999). SCID mice reconstituted with CD4+ 
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T cells or CD8+ T cells are able to control infection (Read et al., 2010). The T cell 
response is thought to rely heavily on the production of IFNγ, as IFNγ-deficient mice 
exhibit high mortality (Andoh et al., 2007). The exact microbicidal programs that IFNγ 
stimulates to control C. burnetii infection remain unclear. T cells are also involved in the 
formation of granulomas, which are thought to be necessary for clearance during acute 
phase because patients with chronic Q fever have fewer granulomas (Koster et al., 
1985a; 1985b). 
     It is known that both infection with C. burnetii and injection of C. burnetii antigens into 
mice induces a significant antibody response in animals and humans (Behymer et al., 
1975; Guigno et al., 1992; Kishimoto and Burger, 1977; Peacock et al., 1979).  Patients 
with acute Q fever have been shown to develop IgM specific antibodies to Phase I 
antigen and IgM, IgG, and IgA antibodies to Phase II antigen, whereas patients with 
chronic Q fever did not produce detectable levels of IgM, but had high levels of both IgA 
and IgG (Worswick and Marmion, 1985). Mixtures of virulent C. burnetii and antibody 
were found to be noninfectious when injected into animals, and studies with formalin-
killed C. burnetii vaccines in humans directly linked antibodies to the control of C. 
burnetii infection (Lackman et al., 1962; Ormsbee et al., 1964; Peacock et al., 1979). 
Administered C. burnetii antibodies were unable, however, to control infection in T cell-
deficient animals, indicating that T cells are necessary for antibody-mediated clearance 
(Andoh et al., 2007; Humphres and Hinrichs, 1981). It is currently hypothesized that a 
successful humoral immune response is necessary to control infection, while a 
successful T cell response is necessary to completely clear C. burnetii from the host. 
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Conclusions 
   Host cells have evolved a variety of mechanisms to recognize and control intracellular 
pathogens. All of these responses rely on the initial detection of the pathogen by innate 
immune sensors that reside at the cell surface or within the host cell cytosol. Coxiella 
burnetii is a poorly understood pathogen that has the potential to cause severe disease 
in humans. While many studies have been done to dissect role individual components 
play in the innate and adaptive control of C. burnetii, different findings have been arrived 
at using cells from different animal origins, immortalized, and primary cells. Here we 
sought to survey the innate immune response mounted by macrophages against the 
Nine Mile Phase II clone 4/RSA439 strain in a well-established system employed in the 
study of many pathogens, macrophages derived from C57BL/6 mice. Since wild-type 
C57BL/6 macrophages are restrictive to C. burnetii growth, we were able to use 
C57BL/6 background mice genetically deficient in key components of the host surface 
and cytosolic surveillance system to examine C. burnetii’s ability to activate canonical 
arms of the innate immune response and decipher the mechanisms underlying cell-
intrinsic control of C. burnetii within C57BL/6 macrophages. 
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Dissertation Aims 
   Intracellular bacteria pose unique challenges to the host immune response. They have 
evolved to live and thrive in specialized intracellular niches, shielded from circulating 
immune challenges in the extracellular space such as antibodies and compliment. 
Despite the presence of a diverse set of innate immune sensors on the host cell surface 
and in the cytosol that can detect microbial pathogens and activate a wide array of 
immune responses, pathogens have evolved strategies to subvert this detection and 
establish infection. 
    One intracellular bacterium, Coxiella burnetii, is a poorly understood pathogen 
capable of causing severe acute and chronic infection in humans. It is the only known 
bacterium to live and replicate in the harsh environment of the lysosome. It also is able 
to survive inside cells over a long period of time and delays recruitment of neutrophils by 
several days. We hypothesize that C. burnetii has evolved strategies to evade or 
delay activation of innate immune pathways in macrophages by either failing to 
activate these pathways or blocking activation through the use of its specialized 
Type IV secretion system (T4SS). While cells from many organisms are consusive to 
productive C. burnetii infection, macrophages from C57BL/6 (B6) mice are able to 
control C. burnetii replication via an unknown mechanism. We, therefore, further 
hypothesize that despite a lack of robust innate immune activation, C. burnetii 
activates a cell-intrinsic innate immune pathway in B6 macrophages. To address 
these overarching hypotheses, we pursued the following specific aims: 
 
Aim 1: Determine which innate immune pathways are activated in mouse 
macrophages following in vitro infection with C. burnetii. In the first aim, we 
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investigated the ability of the C. burnetii Nine Mile Phase II clone 4/RSA439 strain to 
activate various components of the innate immune system in C57BL/6 bone marrow-
derived macrophages. We specifically looked at: the role of surface TLRs and cytosolic 
sensors in production of proinflammatory cytokines, TNF and IL-6; the activation of the 
inflammasome; and the induction of Type I interferons. C57BL/6 naturally restrict C. 
burnetii so we further wanted to determine if these pathways play a role in cell intrinsic 
restriction. To expand upon our hypothesis that C. burnetii evolved strategies to evade 
innate immune detection, we further tested the role of its type IV secretion system in the 
activation of the innate immune response 
 
Aim 2: Determine the mechanism(s) by which TLR-mediated production of TNF 
restricts C. burnetii replication within macrophages. We uncovered TNF as a major 
player in mediating cell-intrinsic restriction of C. burnetii. Since TNF induces a wide array 
of cell-intrinsic immune pathways, we hypothesized that at least one of these pathways 
acts to restrict C. burnetii growth. To test this hypothesis, we focused on three possible 
TNF-mediated restriction mechanisms: activation of cell death via apoptosis and 
necroptosis; the production of reactive nitrogen (RNS) and reactive oxygen (ROS) 
species; and the induction of guanylate binding proteins (GBPs). With each of these 
pathways, we determined if C. burnetii activated these pathways in C57BL/6 
macrophages and then sought to determine if their activation was dependent on TNF 
and if they played a role in cell-intrinsic restriction of C. burnetii. 
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Together, these aims provide new insight into our understanding of the innate immune 
response to C. burnetii in macrophages (Aim 1) and implicated a specific host immune 
pathway in directing cell-mediated control of C. burnetii replication (Aim 2). 
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Figure 1.1 The intracellular lifestyle of C. burnetii. 
C. burnetii is internalized by active phagocytosis or passive binding to leukocyte 
response integrin (αVβ3 integrin) and CR3 receptor. Internalized C. burnetii traffics down 
the canonical endosomal pathway, terminating in an acidic, lysosome-like compartment 
containing Rab5, Rab7, and LAMP-1. 8 hours post internalization, C. burnetii injects 
effector proteins into the host cell cytosol to form its replicative niche, the Coxiella 
containing vacuole (CCV). 24 hours post infection C. burnetii undergoes a morphological 
shift from the infective, metabolically inactive small cell variant (SCV) to the replicative 
large cell variant (LCV). Once the CCV is fully formed, the bacteria replicate inside the 
lysosome-like vacuole at doubling time of ~12 hours. This replication period persists for 
~10 days, with the CCV occupying the majority of the host cell cytosol. At stationary 
phase, C. burnetii reverts back to its infective SSV and exits the cell via an unknown 
mechanism. 
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Abstract 
Detection of intracellular bacterial pathogens by extracellular and cytosolic pattern 
recognition receptors is a critical first step in mediating cell-intrinsic restriction of 
bacterial replication. The intracellular pathogen Coxiella burnetii replicates within 
permissive cell types by using a Dot/Icm type IV secretion system (T4SS) to translocate 
bacterial effectors into the host cell cytosol. C57BL/6 (B6) mouse macrophages do not 
permit replication of the C. burnetii Nine Mile phase II (NMII) strain. However, eliminating 
TLR2 allows C. burnetii NMII to replicate within B6 macrophages, implying that innate 
immune pathways enable B6 macrophages to restrict C. burnetii replication. Whether 
other TLR signaling components or cytosolic immune pathways also sense and restrict 
C. burnetii NMII replication in mouse macrophages remains poorly understood. Here, we 
found that the TLR signaling adaptors MyD88 and Trif are required for cytokine 
production and act in concert to restrict C. burnetii NMII replication. Although we found 
that both TLR2 and TLR4 contribute to proinflammatory cytokine responses to C. burnetii 
NMII, TLR4 is dispensable for control of NMII replication. In addition, we did not observe 
a role for cytosolic sensing of C. burnetii T4SS activity in inflammasome activation or 
production of proinflammatory cytokines and type I interferons, nor did these pathways 
restrict C. burnetii NMII replication. 
 
Introduction 
    To initiate innate immune defense and cell-intrinsic control of intracellular bacterial 
pathogens, host cells utilize pattern recognition receptors (PRRs) to detect pathogen-
associated molecular patterns (PAMPs) (Janeway, 1989; Janeway and Medzhitov, 2002; 
Medzhitov, 2007). Toll-like receptors (TLRs) located at the cell surface and within 
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endosomes detect extracellular PAMPs such as bacterial lipoproteins and 
lipopolysaccharide (LPS) (Akira, 2003). Downstream of TLRs, the adaptor molecules 
MyD88 and Trif activate several signaling pathways, including nuclear factor-kappa B 
(NF-κB), mitogen-activated protein kinases (MAPKs), and interferon regulatory factor 3 
(IRF3), which induce expression of proinflammatory cytokines and other anti-microbial 
effectors important for bacterial clearance (Akira, 2003). Cytosolic PRRs, such as those 
of the Nucleotide Binding Domain/Leucine Rich Repeat (NLR) and RIG-I-like receptor 
(RLR) families, respond to PAMPs introduced into the host cell cytosol by pore-forming 
toxins or specialized secretion systems of intracellular bacterial pathogens (Fritz et al., 
2006; Inohara et al., 2005; Ting et al., 2006). Many cytosolic PRRs synergize with TLR 
signaling for increased proinflammatory cytokine production (Fritz et al., 2006; Oviedo-
Boyso et al., 2014). In addition, a subset of cytosolic PRRs initiate assembly of a 
multiprotein complex termed the inflammasome, which activates the host proteases 
caspase-1 and caspase-11 (Martinon et al., 2002; Miao et al., 2010; Rathinam et al., 
2012). Active caspase-1 initiates a form of cell death known as pyroptosis, a form of cell 
death that can restrict intracellular bacterial infection (Miao et al., 2010; Moltke et al., 
2013; Rathinam et al., 2012). Pyroptosis is accompanied by release of IL-1 family 
cytokines (Miao et al., 2010; Moltke et al., 2013; Rathinam et al., 2012). Active caspase-
11 also induces pyroptosis and IL-1 release (Broz et al., 2012; Gurung et al., 2012; 
Kayagaki et al., 2011; Rathinam et al., 2012). Together, these innate immune pathways 
collaborate to restrict many intracellular bacterial pathogens through cell-intrinsic and 
extrinsic mechanisms. 
     Coxiella burnetii is a facultative intracellular, gram-negative bacterium responsible for 
the zoonotic disease Q (query) fever, an acute flu-like illness that can progress to a 
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severe, chronic disease that often manifests as severe endocarditis (Maurin and Raoult, 
1999). C. burnetii exists as two phase variants. Virulent phase I C. burnetii synthesizes 
LPS with a highly branched O-chain, which shields the bacteria from complement-
mediated killing in serum and prevents binding of antibodies to cell surface (Hackstadt, 
1988; Vishwanath and Hackstadt, 1988). In contrast, lab-adapted avirulent phase II C. 
burnetii produce a truncated O-antigen polysaccharide and are trafficked to fully mature 
lysosomes in B6 macrophages (Amano et al., 1987; Howe et al., 2010; Moos and 
Hackstadt, 1987). A cloned phase II variant of the C. burnetii Nine Mile reference strain 
(NMII; RSA493 clone 4) contains a ~26-kb chromosomal deletion that eliminates several 
genes involved in LPS biosynthesis and is avirulent in immunocompetent mice and 
guinea pigs (Hoover et al., 2002; Moos and Hackstadt, 1987). NMII is a biosafety level 2 
organism, whereas all other C. burnetii strains require biosafety level 3. Although the 
NMII strain is unable to establish systemic infection in animals, the NMII strain and the 
isogenic phase I strain (NMI) are indistinguishable in their ability to replicate in human 
and mouse macrophage cell lines and primary human macrophages in vitro (Baca et al., 
1981; Graham et al., 2013; Howe et al., 2010) . There is no difference in the ability of 
NMI and NMII to elicit the proinflammatory cytokines TNF and IL-6 from human 
macrophages, but there are differences in the induction of other cytokines such as IL-1β, 
suggesting that macrophages mount both overlapping and distinct immune responses to 
NMI and NMII during in vitro infection (Graham et al., 2013; Howe et al., 2010).  
    Once inside host cells, the C. burnetii-containing vacuole is directed down the 
canonical endosomal pathway, while also engaging the autophagy and early secretory 
pathways to form a lysosome-derived vacuole. (Heinzen et al., 1996; Romano et al., 
2007) Within this compartment, C. burnetii is able to resist the bactericidal activities of 
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the lysosome and replicate for several days (Coleman et al., 2004; Heinzen et al., 1996). 
To establish this unique intracellular niche, C. burnetii utilizes a Dot/Icm type IVB 
secretion system to translocate over 100 effector proteins into the host cytosol (Beare et 
al., 2011; Carey et al., 2011; Chen et al., 2010; Graham et al., 2015; Lifshitz et al., 2013; 
Pan et al., 2008; Voth et al., 2011; 2009). These effector proteins are predicted to target 
and manipulate host cell factors, with several effectors established as having roles in 
intracellular membrane trafficking and inhibition of host cell apoptosis (Graham et al., 
2015; Klingenbeck et al., 2013; Lührmann and Roy, 2007; van Schaik et al., 2013).  
    The evolutionarily related pathogen Legionella pneumophila, which causes the severe 
pneumonia Legionnaires’ disease, primarily associates with freshwater amoebae (Fields, 
1996). Because L. pneumophila has evolved to infect protozoa, it is thought that L. 
pneumophila has not evolved evasion strategies to purposely subvert mammalian innate 
immune pathways and thus has been a useful model for uncovering innate immune 
pathways used by macrophages to restrict intracellular bacterial infection (Shin and Roy, 
2008). In support of this, whereas A/J macrophages are permissive for L. pneumophila 
replication, C57BL/6 macrophages restrict L. pneumophila replication (Yoshida et al., 
1991). Studying how C57BL/6 macrophages control L. pneumophila replication has 
allowed for the identification of TLR-dependent and cytosolic PRR-dependent immune 
pathways that collaborate to restrict L. pneumophila replication, such as the 
proinflammatory cytokines TNF and type I IFNs and inflammasome-dependent pyroptotic 
cell death. Importantly, activation of the inflammasome and other cytosolic immune 
pathways requires a functional L. pneumophila Dot/Icm T4SS that translocates bacterial 
products, such as flagellin, into the host cell cytosol.  
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   Primary mouse macrophages of the C57BL/6 genetic background, in contrast to other 
inbred backgrounds, are not permissive for C. burnetii NMII infection (Zamboni, 2004; 
Zamboni et al., 2002). In contrast to L. pneumophila, how B6 mouse macrophages 
detect C. burnetii NMII and restrict intracellular replication of NMII remains poorly 
understood. TLR2 plays a major role in the production of proinflammatory cytokines and 
elimination of TLR2 signaling renders C57BL/6 macrophages more permissive for 
intracellular C. burnetii NMII replication (Zamboni et al., 2004). This indicates that innate 
immune sensing plays a critical role in restricting NMII replication in C57BL/6 
macrophages. Furthermore, these findings suggest that C57BL/6 macrophages are a 
useful model for uncovering cell-intrinsic immune mechanisms that control intracellular 
C. burnetii NMII replication.  
    In contrast to TLR2, TLR4 is thought to be dispensable for immune responses against 
C. burnetii, as C. burnetii lipid A is a TLR4 antagonist (Shannon et al., 2005; Zamboni et 
al., 2004). Whether other TLRs might work in concert with TLR2 to detect and control C. 
burnetii NMII infection is unknown. Similarly, the roles of the TLR signaling adaptors 
MyD88 and Trif in mediating macrophage sensing and control of C. burnetii NMII is also 
unknown. Since C. burnetii encodes a Dot/Icm T4SS that translocates bacterial products 
into the host cell cytosol, it would be predicted that intracellular PRRs are activated that 
would restrict NMII replication (Beare et al., 2009; Newton et al., 2013; Segal et al., 
2005; van Schaik et al., 2013). C. burnetii NMII is capable of translocating T4SS 
effectors into C57BL/6 macrophages, indicating that the block in bacterial replication 
may occur at a step following T4SS effector translocation (Newton et al., 2013). Indeed, 
the cytosolic sensor NOD2 was shown to contribute to cytokine production during 
infection with C. burnetii phase I organisms, demonstrating the potential for C. burnetii to 
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be detected by cytosolic surveillance pathways (Ammerdorffer et al., 2014; Benoit et al., 
2009). Whether cytosolic immune pathways detect and restrict C. burnetii NMII infection 
in B6 macrophages is not known. 
    Here, we set out to identify whether additional TLR or cytosolic immune signaling 
pathways are used by C57BL/6 mouse macrophages to detect and restrict C. burnetii 
NMII during in vitro infection. In addition to the established role for TLR2 in responding to 
NMII and mediating proinflammatory cytokine production, we find that TLR2 and TLR4 
work in concert to mediate cytokine responses to NMII, but we observe that TLR4 does 
not significantly contribute to the control of NMII replication. Furthermore, the TLR 
signaling adaptors MyD88 and Trif are both required for cytokine responses to NMII and 
restricting intracellular bacterial replication. Despite the ability of the C. burnetii NMII 
T4SS to translocate bacterial products into the cytosol of B6 macrophages, we did not 
observe inflammasome activation or an increase in pro-inflammatory cytokine production 
in response to C. burnetii NMII compared to isogenic mutants lacking a functional T4SS. 
In addition, the key inflammasome caspases, caspase-1 and caspase-11, were 
dispensable for control of intracellular NMII replication within B6 macrophages. We also 
did not detect robust induction of type I interferons by NMII, nor did we see a role for 
type I IFNs in restricting intracellular replication.  
 
Materials and Methods 
Ethics statement 
All experiments performed in this study involving mice, solely used as a tissue source, 
were done so in accordance with the Animal Welfare Act (AWA) and the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the 
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National Institutes of Health. The Institutional Animal Care and Use Committee of the 
University of Pennsylvania approved all procedures (protocols #803465, #803459, 
#804714, and #804928). 
 
Bacteria Strains 
Coxiella burnetii Nine Mile Phase II (clone 4; RSA 439) and Legionella pneumophila 
serogroup 1 background strains were used in all experiments (Berger and Isberg, 1993).  
For C. burnetii infections, acidified citrate cysteine medium (ACCM-2) was inoculated 
with WT C. burnetii (Omsland et al., 2013), WT C. burnetii expressing mCherry (Beare et 
al., 2009), icmL::Tn strain (Carey et al., 2011), which contains a transposon insertion in 
the icmL gene rendering the T4SS non-functional, and WT and icmL::Tn strains 
harboring a plasmids encoding BlaM alone and BlaM fused to known T4SS substrate 
CBU_0077 under control of the CBU_1169 promoter (Carey et al., 2011; Newton et al., 
2013). C. burnetii was grown at 37°C in 5% CO2 and 2.5% O2 for 6 days to late log 
phase (~1.0x109 bacteria/mL). One day after inoculation, kanamycin (275 μg/mL) was 
added to icmL::Tn cultures and chloramphenicol (3 μg/mL) was added to strains 
harboring plasmids encoding BlaM and BlaM-0077 fusion proteins (Carey et al., 2011). 
To quantify C. burnetii genome equivalents for infection of macrophages, C. burnetii 
genomic DNA was isolated with the illustraTM bacteria genomicPrep Mini Spin Kit (GE 
Healthcare), and genomic equivalents were measured by quantitative PCR of the C. 
burnetii dotA gene using SYBR Green, the CFX96 qPCR machine (Bio-Rad 
Laboratories), and the following primers: dotA 5’ (GCGCAATACGCTCAATCACA), dotA 
3’ (CCATGGCCCCAATTCTCT). L. pneumophila ΔdotA (Berger et al., 1994),  ΔflaA 
(Ren et al., 2006), and ΔdotA and ΔflaA harboring the pSS128 encoding a blam-RalF 
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fusion plasmid on the Lp02 (thyA) background, a thymidine auxotroph derived from 
strain Lp01, were cultured as a heavy patch on charcoal yeast extract agar containing 
thymidine for 48 hours at 37°C (Copenhaver et al., 2014). L. pneumophila and C. burnetii 
strains harboring plasmids encoding the BlaM reporter proteins were grown in the 
presence of chloramphenicol at 6.75 μg/mL and 3 μg/mL, respectively. 
 
Mammalian Cell Culture 
Bone marrow was isolated from the femurs, tibia, and humeri of C57BL/6 (Jackson), 
Tlr2-/- (Takeuchi et al., 1999), Tlr4-/- (Hoshino et al., 1999), Tlr2-/-Tlr4-/-, Myd88-/- (Adachi et 
al., 1998), Trif-/- (Yamamoto et al., 2003), Myd88-/-Trif-/-, and Ifnar-/- (Müller et al., 1994) 
mice . Bone marrow cells were differentiated into macrophages for 7-8 days in RPMI 
containing 30% L929 cell supernatant and 20% FBS at 37°C in a humidified incubator 
(Casson et al., 2013). Macrophages were lifted with ice-cold PBS + 2 mM EDTA and 
replated one day prior to infection in RPMI containing 15% L929 cell supernatant and 
10% FBS. Macrophages were plated into 48 or 24 well plates at 1.5x105 or 2.0x105 cells 
per well, respectively. Macrophages were infected with various MOIs of C. burnetii and 
L. pneumophila as indicated. C. burnetii and L. pneumophila bacteria were washed once 
with PBS prior to infection of macrophages. After infection, cells were spun at 1200 RPM 
for 5 minutes prior to incubation at 37˚C. At designated timepoints, macrophage 
supernatants, whole cell lysates, or mRNA were collected. 
 
Immunoblot Analysis 
Cell lysates were collected with 1X SDS-PAGE sample buffer or supernatants were 
mixed 1:1 with 2X SDS-PAGE buffer containing protease and phosphatase inhibitors. 
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Samples were boiled for 5 minutes, separated by SDS-PAGE and transferred to 
Immobilon P membranes (Millipore). Primary antibodies specific for phospho-p38 and 
p38 MAPK (Cell Signaling Technology), caspase-1 p10 (Santa Cruz Biotechnology), IL-
1β (R&D Systems), and β-actin (Sigma) were used. Detection was performed with HRP-
conjugated anti-rabbit antibodies (Cell Signaling Technology), anti-mouse antibodies 
(Cell Signaling Technology), or anti-rat antibodies (Jackson ImmunoResearch). 
 
ELISA 
Harvested supernatants from infected macrophages were assayed for cytokines using 
capture and detection antibodies specific for TNF, IL-6, IL-1α, and IL-1β (BD 
Biosciences). 
 
Cytotoxicity Assay 
Cells were infected with WT C. burnetii for 24 hours or treated with 0.5 μg/mL LPS for 4 
hours and 2.5 mM ATP for 1 hour. Supernatants were harvested and used to measure % 
cytotoxicity via lactate dehydrogenase (LDH) release using the LDH Cytotoxicity Assay 
Kit (Clontech).  
 
Measuring Intracellular Coxiella burnetii Replication 
Measuring intracellular replication of C. burnetii in C57BL/6, Tlr2-/-, Tlr4-/-, Tlr2-/-Tlr4-/-, 
Myd88-/-, Trif-/-, Myd88-/-Trif-/-, or Ifnar-/- BMDMs was performed as follows. Macrophages 
were infected with C. burnetii Nine Mile Phase II expressing mCherry at MOI=100 in 24 
well plates (Beare et al., 2011). 24 hours post-infection, cells were washed 3 times with 
PBS to remove extracellular bacteria and fresh media was added to the cells every 2 
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days. At designated timepoints post-infection, the extracellular media was collected and 
the adherent macrophages were lysed with 1mL sterile dH2O. The lysed samples were 
then combined with the extracellular media from the same well. Bacterial genomic DNA 
was purified and C. burnetii genomic equivalents (GE) were measured via qPCR using 
primers specific for the C. burnetii dotA gene. The fold change in bacterial GEs was 
calculated as a ratio of the number of GEs on a given day to the number of GEs on day 
1.  
 
Enumeration of Coxiella burnetii-containing vacuoles by microscopy 
2.0 x 105 cells were plated onto a glass coverslip per well in triplicate in 24 well plates for 
each condition. Seven days post-infection, cells were washed with PBS, stained with 
DAPI, and fixed with 4% paraformaldehyde. Images were taken with a Nikon Eclipse 
2000E-U epifluorescence microscope and images were acquired with NIS Elements B4 
4.10.01 software. Large vacuoles (> 5 μM) containing mCherry-expressing C. burnetii 
were enumerated as a percentage of total DAPI-positive cells. For each coverslip, 
greater than 300 cells were counted.  
 
Quantitative RT-PCR 
RNA was isolated from infected macrophages using the RNeasy Mini kit and DNase-
treated using the RNase-free Dnase set (Qiagen) to remove contaminating genomic 
DNA. The isolated RNA was then reverse transcribed into cDNA using Superscript II 
reverse transcriptase (Invirogen). Relative mRNA abundance was measured by qPCR 
using SYBR Green and the CFX96 qPCR machine (Bio-Rad Laboratories). The following 
primer pairs were used: Ifnb 5’ (GCACTGGGTGGAATGAGACTATTG), Ifnb 3’ 
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(TTCTGAGGCATCAACTGACAGGTC), Ifna4 5’ (CCCACAGCCCAGAGAGTGACC), 
Ifna4 3’ (GGCCCTCTTGTTCCCGAGGT), Hprt 5’ (GTTGGATACAGGCCAGACT), Hprt 
3’ (GAGGGTAGGCTGGCCTAT).  To calculate relative fold induction using the ΔΔCT 
method, the cycle threshold (Ct) of a given gene was normalized to HPRT Ct and 
compared to the normalized Ct in uninfected cells. 
 
Viral Proliferation Bioassay 
The viral proliferation bioassay was performed as previously described, with some 
modifications as follows (Park et al., 2003). Briefly, C57BL/6 macrophages were mock 
infected, treated with Poly (I:C) (Invivogen), or infected with L. pneumophila ΔflaA at 
MOI=5 or WT C. burnetii NMII at MOI=50 for 24 hours. Supernatants were collected and 
UV-inactivated by exposure to 600 mJoules·cm-2 UVA light in a Stratalinker 1800 
(Stratagene). L2 mouse fibroblasts were treated with UV-inactivated supernatants for 24 
hours and then infected with Newcastle disease virus expressing green fluorescent 
protein (NDV-GFP) at an MOI of 1 plaque-forming unit (PFU)/cell. At 24 hours post-
infection, cells were fixed, stained with DAPI, and examined under an Eclipse TE2000-U 
epifluorescence microscope (Nikon Instruments, Inc.). Images were acquired using NIS 
Elements B4 4.10.01 software (Nikon Instruments, Inc.).  Mean GFP fluorescence 
intensity was determined using ImageJ, with background fluorescence determined from 
mock viral-infected samples. For each sample, the mean of three random fields of equal 
area was quantified. Images and quantification are representative of two independent 
experiments. 
 
Effector Translocation Assay 
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Translocation of BlaM-effector fusion proteins was performed as previously described 
(Copenhaver et al., 2014; Newton et al., 2013). 5.0x105 BMDMs were seeded over night 
in 12 well non-TC coated dishes. Cells were infected at indicated MOIs. 16 hours post-
infection, cells were loaded with the fluorescent substrate CCF4-AM, using the Live 
BLAzer-RET B/G Loading Kit with 15 mM probenecid, in the dark for 90 min at room 
temperature (Copenhaver et al., 2014; Newton et al., 2013). Cells were gated on live 
singlets that had retained the CCF4-AM dye.  
 
Treatment of B6 Macrophages with Purified Coxiella burnetii Nine Mile phase II 
LPS 
LPS from Nine Mile Phase II C. burnetii was purified as previously described (Zamboni 
et al., 2004) and resuspended in deionized water. C57BL/6 bone marrow derived 
macrophages were plated in 96 wells at 1.0x105 cells per well for a total volume of 100 
μL. Cells were treated with 0, 100, and 1000 ng/mL of C. burnetii for 24 hours. To ensure 
the purified LPS was present, we tested its previously described ability to antagonize E. 
coli LPS (Zamboni et al., 2004). 30 minutes post addition of C. burnetii LPS, we added 0, 
0.1, 1, and 10 ng/mL E. coli LPS. Cells were incubated for 24 hours and TNF levels were 
measured via ELISA. 
 
Statistical Analysis 
The plotting of data and statistical analysis were performed using GraphPad Prism 
software. Statistical significance was determined using unpaired, two-tailed Student’s t 
test or one-way analysis of variance (ANOVA) with Tukey’s posttest. Differences were 
considered significant if the P value was <0.05. 
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Results 
Both TLR2 and TLR4 mediate cytokine responses to Coxiella burnetii Nine Mile 
phase II in mouse macrophages. 
    Production of pro-inflammatory cytokines in response to C. burnetii infection has 
previously been reported to depend largely on TLR2 signaling (Ammerdorffer et al., 
2014; Zamboni et al., 2004). However, the roles of other TLRs or the signaling adaptors 
MyD88 or Trif in macrophage responses to C. burnetii are largely unknown. In particular, 
it is unclear if TLR4 contributes to the immune response to C. burnetii. TLR4-deficient 
mice have a defect in cytokine production during C. burnetii infection in vivo (Honstettre 
et al., 2004), but the lipid A of C. burnetii is thought to be an antagonist of TLR4 and 
macrophages lacking a functional TLR4 do not exhibit a defect in cytokine production 
(Zamboni et al., 2004). Given that TLR2 responds so strongly to C. burnetii, we 
wondered whether a role for TLR4 could be revealed in the absence of TLR2 signaling. 
Thus, we infected B6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- bone marrow-derived macrophages 
(BMDMs) with C. burnetii NMII and measured secreted levels of TNF and IL-6 at 24 
hours post infection. We observed a significant reduction in TNF and IL-6 production in 
infected Tlr2-/- BMDMs and no difference in cytokine production in infected Tlr4-/- 
BMDMs, consistent with previous published studies (Figures 2.1A and 2.1B). However, 
BMDMs lacking TLR2 still produced substantial levels of TNF and IL-6 following C. 
burnetii infection at an MOI of 50, indicating that an additional TLR also contributes to 
cytokine production. In contrast, BMDMs lacking both TLR2 and TLR4 did not produce 
detectable levels of TNF and IL-6 in response to C. burnetii infection at an MOI of 50, 
indicating a role for TLR4 in sensing C. burnetii that is unmasked in the absence of 
TLR2.  
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    B6 BMDMs do not permit robust intracellular C. burnetii replication (Zamboni, 2004). 
Restriction of C. burnetii replication is in part mediated through TLR2 signaling, as TLR2-
deficient BMDMs are significantly more permissive for C. burnetii replication (Zamboni et 
al., 2004). To test if restriction of C. burnetii replication also involves TLR4, we infected 
B6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- BMDMs with WT C. burnetii expressing mCherry and 
measured bacterial uptake (Figure 2.8A) on day 1 post-infection, and intracellular 
replication (Figure 2.1C) and vacuole formation (Figures 2.1D and 2.1E) at day 7 post-
infection. Similar levels of bacterial uptake were observed for the different genotypes of 
mouse macrophages. In agreement with previous findings, B6 and Tlr4-/- BMDMs limited 
bacterial replication, whereas TLR2-deficient BMDMs were more permissive for 
intracellular C. burnetii replication. Tlr2-/-Tlr4-/- BMDMs were not more permissive for C. 
burnetii replication when compared to Tlr2-/- BMDMs, suggesting that concomitant 
deletion of both TLR2 and TLR4 does not increase macrophage susceptibility to C. 
burnetii replication, despite decreased cytokine production.  
 
The TLR signaling adaptors MyD88 and Trif are critical for cytokine production 
and cell-intrinsic control of intracellular Coxiella burnetii replication in mouse 
macrophages.  
    Because TLR2 primarily signals through the adaptor protein MyD88, whereas TLR4 
signals through both MyD88 and Trif (Akira, 2003), we next examined the roles of 
MyD88 and Trif in mediating cytokine responses to C. burnetii. Myd88-/- BMDMs 
produced significantly lower, but still substantial, levels of TNF and IL-6 compared to WT 
BMDMs following C. burnetii infection at an MOI of 50 (Figures 2.2A and 2.2B). Trif-/- 
BMDMs similarly produced significantly lower, but substantial, levels of TNF and IL-6 
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compared to WT BMDMs. In contrast, Myd88-/-Trif-/- BMDMs did not produce detectable 
levels of TNF or IL-6, suggesting that both MyD88 and Trif signaling contribute to 
cytokine production during C. burnetii infection. Thus, in addition to confirming that TLR2 
is a major sensor of C. burnetii, these data implicate a role for TLR4 and/or another Trif-
dependent TLR in responding to C. burnetii NMII and mediating cytokine production.  
    To test if MyD88 and Trif also contribute to the restriction of C. burnetii replication, we 
infected B6, Myd88-/-, Trif-/-, and Myd88-/-Trif-/- BMDMs with WT C. burnetii expressing 
mCherry and measured bacterial uptake (Figure 2.8B) on day 1 post-infection as well as 
intracellular replication (Figure 2.2C) and vacuole formation (Figures 2.2D and 2.2E) at 
day 7 post-infection. Similar levels of bacterial uptake were observed for the different 
genotypes of BMDMs. When we examined the levels of intracellular C. burnetii 
replication at day 7 post-infection, we found that Myd88-/- BMDMs were significantly more 
permissive than B6 BMDMs, whereas Trif-/- BMDMs did not exhibit increased bacterial 
growth. BMDMs deficient in both Myd88 and Trif were more permissive than MyD88-
deficient BMDMs for intracellular C. burnetii growth, as measured by both increased GEs 
and vacuole number. These data indicate that both MyD88 and Trif mediate cytokine 
production and restriction of intracellular C. burnetii replication in B6 BMDMs. 
 
Purified Coxiella burnetii LPS does not induce TNF production. 
   Since we observed a role for TLR4 in the production of TNF, we wanted to test if 
purified C. burnetii Nine Mile Phase II LPS was capable of stimulating TNF production in 
our system. C57BL/6 failed to produce TNF in response to two concentrations of C. 
burnetii LPS, 100 ng/mL or 1000 ng/mL (Figure 2.3). To confirm our sample contained 
functional C. burnetii LPS, we performed an LPS antagonism assay, as C. burnetii LPS 
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has been reported to be antagonistic (Zamboni et al., 2004). Cells were pretreated with 
C. burnetii LPS and then stimulated with different doses of E. coli LPS ranging from 0.1 
to 10 ng/mL(Zamboni et al., 2004). We saw that C. burnetii LPS antagonized the 
stimulatory activity ofE. coli LPS similarly to the previous study (Figure 2.3). These data 
suggest that C. burnetii LPS alone fails to stimulate TLR4. TLR4-induced TNF production 
could require a second signal from TLR2 or may be stimulated by another yet-to-be-
identified bacterial or host ligand. 
 
Coxiella burnetii translocates effector proteins into B6 macrophages. 
    To confirm that C. burnetii in our system was capable of translocating bacterial 
products into the host cell cytosol, we used a β-lactamase reporter system to measure 
T4SS effector translocation. As positive and negative controls, we used the L. 
pneumophila ΔflaA strain and ΔdotA strain, which lack a functional T4SS, both harboring 
a plasmid encoding a translational fusion of the E. coli TEM-1 β-lactamase (BlaM) and 
the T4SS effector RalF. RalF is a L. pnemophila effector that is robustly translocated into 
host cells (Copenhaver et al., 2014). For C. burnetii, we used WT and icmL::Tn Nine Mile 
Phase II carrying a plasmid encoding BlaM translationally fused to CBU_0077, a C. 
burnetii effector protein previously shown to be translocated into macrophages at 
relatively early time points, by 4 to 8 hours post-infection (Newton et al., 2013). 
Translocation of the fusion proteins was detected in host cells by means of the 
membrane-permeable BlaM substrate CCF4-AM (Zlokarnik et al., 1998). CCF4-AM 
consists of coumarin joined to fluorescein by a β-lactam ring. When excited at 409nm, 
fluorescence resonance energy transfer (FRET) between coumarin and fluorescein 
results in green fluorescence emission at 518nm. T4SS-injected BlaM will cleave the 
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CCF4-AM substrate in the host cytosol and eliminate FRET, thus resulting in blue 
fluorescence emission at 447nm. As expected, the L. pneumophila ΔflaA strain robustly 
translocated RalF into macrophages, whereas the ΔdotA strain was unable to 
translocate (Figure 2.4). At 16 hours post-infection, with the Nine Mile Phase II strains 
expressing BlaM-0077, we were able to see dose-dependent injection into C57BL/6 
macrophages infected with WT, but not icmL::Tn (Figure 2.4). This confirms that in our 
system, C. burnetii is capable of introducing bacterial products into the cytosol of 
replication-restrictive C57BL/6 macrophages. 
 
Coxiella burnetii T4SS activity does not enhance cytokine production. 
    Cytosolic sensing of bacterial products translocated into the host cell cytosol by 
specialized secretion systems can contribute to increased cytokine production and 
restriction of bacterial replication. In the case of L. pneumophila, cytosolic sensing of 
T4SS-translocated products leads to enhanced cytokine production (Shin et al., 2008). 
C. burnetii NMII is capable of translocating T4SS effectors into C57BL/6 macrophages 
(Newton et al., 2013), but whether cytosolic sensing of C. burnetii T4SS activity might 
similarly lead to increased pro-inflammatory cytokine production is unknown. To test this 
possibility, we infected WT macrophages with WT C. burnetii or T4SS-deficient C. 
burnetii (icmL::Tn) containing an inactivating transposon insertion in the icmL gene 
(Carey et al., 2011). We then measured production of pro-inflammatory cytokines TNF 
and IL-6. As a positive control for T4SS-dependent cytokine production, we used L. 
pneumophila ΔflaA, which express a functional T4SS but lack flagellin to bypass NAIP5 
inflammasome activation and host cell death in B6 BMDMs (Ren et al., 2003), or L. 
pneumophila ΔdotA, which lack a functional T4SS (Berger et al., 1994). As previously 
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demonstrated, L. pneumophila ΔflaA infection induced increased production of TNF and 
IL-6 compared to infection with L. pneumophila ΔdotA. In contrast, we did not observe 
enhanced TNF or IL-6 production in BMDMs infected with WT C. burnetii compared to 
infection with C. burnetii icmL::Tn in restrictive C57BL/6 or permissive Tlr2-/- (Figures 
2.5A-D). Moreover, in contrast to increased T4SS-dependent expression of pro-IL-1β in 
response to L. pneumophila ΔflaA compared to ΔdotA infection, we did not observe 
differential expression of pro-IL-1β between WT and C. burnetii icmL::Tn (Figure 2.6H). 
These findings suggest cytosolic sensing of C. burnetii’s T4SS does not lead to 
increased production of the pro-inflammatory cytokines TNF, IL-6, or pro-IL-1β. We did, 
however, consistently observe a slight decrease in cytokine production in cells infected 
with WT C. burnetii compared to cells infected with IcmL-deficient bacteria, suggesting 
that C. burnetii T4SS activity may somehow diminish production of pro-inflammatory 
cytokines.  
 
Early p38 MAPK activation in response to Coxiella burnetii infection is mediated 
by TLR signaling. 
    Upon detection of PAMPs by surface and cytosolic PRRs, signaling events that 
involve phosphorylation and activation of host MAPKs contribute to the generation of a 
pro-inflammatory transcriptional response (Janeway and Medzhitov, 2002). For example, 
L. pneumophila induces rapid p38 MAPK activation within 20 minutes post-infection that 
involves both TLR signaling as well as cytosolic sensing of T4SS-translocated bacterial 
effectors (Fontana et al., 2012; Shin et al., 2008). p38 MAPKs are activated and 
contribute to cytokine production during C. burnetii infection, but the mechanistic basis 
for MAPK activation in response to C. burnetii is unknown (Ammerdorffer et al., 2014; 
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Barry et al., 2012; Voth and Heinzen, 2009). To test if p38 MAPK phosphorylation shortly 
after C. burnetii infection requires TLR signaling, we infected B6 and Myd88-/- BMDMs 
with WT C. burnetii and examined p38 MAPK phosphorylation up to two hours post-
infection (Figure 2.5E). We observed robust phosphorylation of p38 MAPK in B6 
macrophages, but p38 MAPK phosphorylation was attenuated in MyD88-deficient 
BMDMs, suggesting that early p38 MAPK activation in response to C. burnetii is largely 
TLR-dependent and is not robustly triggered by cytosolic immunosurveillance pathways.  
 
Inflammasomes are not activated by Coxiella burnetii in mouse macrophages and 
do not restrict intracellular replication.  
    Bacterial ligands introduced into the host cell cytoplasm by virulence-associated 
specialized secretion systems can be sensed by cytosolic PRRs (Fritz et al., 2006; 
Inohara et al., 2005; Ting et al., 2006). A subset of cytosolic PRRs trigger the assembly 
of a multi-protein cytosolic complex termed the inflammasome. Inflammasomes recruit 
and activate the host proteases caspase-1 and caspase-11, which regulate an 
inflammatory cell death termed pyroptosis and promote the release of IL-1 family 
cytokines, including IL-1α, IL-1β, and IL-18 (Martinon et al., 2002; Miao et al., 2010; 
Rathinam et al., 2012). This inflammatory cell death can restrict intracellular bacterial 
replication and contributes to a systemic in vivo immune response involving neutrophil 
recruitment and IFNγ production and subsequent bacterial clearance. Infection with 
T4SS-expressing L. pneumophila leads to robust activation of multiple inflammasomes, 
including a flagellin-dependent NAIP5 inflammasome, an NLRP3 inflammasome that 
responds to an unidentified T4SS-dependent signal, and a caspase-11 inflammasome 
that detects hexa-acylated or penta-acylated lipid A (Case and Roy, 2011; Case et al., 
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2013; 2009; Casson et al., 2013; Hagar et al., 2013; Kayagaki et al., 2011; Molofsky, 
2006; Ren et al., 2006; Shi et al., 2014; Zamboni et al., 2006). C. burnetii does not 
contain genes encoding flagellin and thus would not be expected to activate the NAIP5 
inflammasome (Seshadri et al., 2003). Furthermore, C. burnetii expresses tetra-acylated 
lipid A, which is thought to be non-stimulatory for caspase-11, and thus would not be 
expected to activate the caspase-11 inflammasome (Hagar et al., 2013; Kayagaki et al., 
2011; Zamboni et al., 2004). However, whether C. burnetii infection induces activation of 
the NLRP3 inflammasome or other inflammasomes is unknown. To test if C. burnetii 
infection of mouse macrophages leads to inflammasome activation, we first infected B6 
BMDMs with C. burnetii and measured secretion of the inflammasome-dependent 
cytokines IL-1α and IL-1β, as well as cell death. As a positive control for inflammasome 
activation, we infected BMDMs with L. pneumophila ΔflaA, which lack flagellin and are 
unable to activate the NAIP5 inflammasome but still activate the NLRP3 and caspase-11 
inflammasomes. As expected, infection with L. pneumophila ΔflaA at an MOI of 5 
induced robust release of both IL-1α and IL-1β (Figures 2.6A and B). In contrast, we 
were unable to detect released IL-1α and IL-1β in the supernatant of C. burnetii-infected 
cells even at a high MOI of 100 at 24 hours post-infection, suggesting that C. burnetii 
infection fails to induce inflammasome-dependent cytokine secretion(Figures 2.6A and 
2.6B). Furthermore, we did not detect cell death 24 hours post-infection in C. burnetii-
infected cells, whereas treatment with the NLRP3 inflammasome stimulus LPS + ATP 
induced robust cell death (Figure 2.6C). 
    Inflammasome activation is a two step process that requires an initial ‘priming’ signal, 
often TLR signaling, to upregulate the expression of inflammasome components, 
including pro-IL-1β, followed by a second ‘activation’ signal involving cytosolic detection 
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of bacterial PAMPs (Fontana and Vance, 2011). WT C. burnetii infection is capable of 
priming macrophages, as measured by detection of pro-IL-1β in the lysates of B6 
BMDMs infected with WT C. burnetii at MOIs ranging from 20 to 100 (Figure 2.6G); 
however, the levels of pro-IL-1β induced in C. burnetii-infected B6 BMDMs even at an 
MOI of 100 were substantially lower than in BMDMs infected with L. pneumophila at an 
MOI of 5, indicating that C. burnetii does not prime BMDMs as robustly as L. 
pneumophila. Thus, it is possible that the level of priming induced by C. burnetii infection 
is insufficient for inflammasome activation and subsequent IL-1α and IL-1β release. To 
test this possibility, we next pre-primed B6 BMDMs with E. coli LPS for 4 hours, an 
established method of inflammasome priming that induces robust expression of pro-IL-
1β and other inflammasome components (Casson et al., 2013). We then infected LPS-
primed cells with L. pneumophila ΔflaA or WT C. burnetii NMII and measured secreted 
IL-1α and IL-1β (Figures 2.6D and 2.6E). Mock-infected, LPS-primed BMDMs did not 
release IL-1α or IL-1β into the supernatant, as LPS-priming alone is insufficient for 
inflammasome activation, whereas L. pneumophila ΔflaA-infected primed BMDMs 
released substantial levels of IL-1α and IL-1β by 24 hours post-infection. In contrast, we 
were unable to detect secreted IL-1α or IL-1β in the supernatants of LPS-primed cells 
infected with WT C. burnetii at MOIs ranging from 20 to 100 for 24 hours, suggesting that 
even following LPS-priming, C. burnetii NMII infection fails to induce inflammasome-
dependent cytokine secretion. We next examined whether the failure to detect 
inflammasome-dependent cytokine secretion was due to an upstream defect in caspase-
1 activation by assaying for caspase-1 processing into a mature 10kD-sized fragment 
(p10) and its release into the supernatant of infected cells (Figure 2.6H) Mock-infection 
of LPS-primed BMDMs did not result in caspase-1 processing and release, whereas L. 
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pneumophila ΔflaA infection led to caspase-1 processing into a detectable p10 form. In 
contrast, caspase-1 processing was undetectable following WT C. burnetii infection at all 
MOIs tested. These data indicate that C. burnetii NMII infection can lead to the 
upregulation of inflammasome-related genes such as pro-IL-1β, but C. burnetii T4SS 
activity does not trigger inflammasome activation following infection of mouse 
macrophages. Moreover, despite similar levels of internalized bacteria at 24 hours post-
infection (Figure 2.8C), we did not detect increased C. burnetii replication in Casp1-/-
Casp11-/- BMDMs, in contrast to Tlr2-/- BMDMs (Figure 2.6F), further demonstrating that 
inflammasomes do not play a critical role in controlling intracellular C. burnetii replication 
in B6 BMDMs. 
 
Type I interferons are not robustly induced by Coxiella burnetii and do not restrict 
intracellular replication in mouse macrophages. 
    Many intracellular bacterial pathogens stimulate the production of type I interferon 
(IFN) in infected host cells (Monroe et al., 2010). Induction of type I IFNs is regulated in 
part by extracellular sensors, such as TLR4, as well as cytosolic sensors, such as the 
RNA sensors RIG-I and MDA-5, the DNA sensor cGAS, or the cyclic dinucleotide sensor 
STING (Burdette and Vance, 2013; Dempsey and Bowie, 2015; Monroe et al., 2010; 
Paludan, 2015). In some bacterial infections, such as L. pneumophila, type I IFNs 
promote bacterial clearance (Coers et al., 2007; Lippmann et al., 2011; Schiavoni et al., 
2004), while in other infections, such as M. tuberculosis, activation of type I IFNs is 
detrimental to the host (Manzanillo et al., 2012). Whether C. burnetii induces type I IFNs 
upon infection of macrophages is unknown. To test if C. burnetii activates a type I IFN 
response, we infected B6 BMDMs with WT C. burnetii and measured levels of Ifna4 and 
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Ifnb mRNAs by quantitative RT-PCR (Figures 2.7A and 2.7B). We were unable to detect 
transcriptional induction of IFNα4 or IFNβ 16 hours post infection, suggesting that C. 
burnetii does not robustly induce expression of type I IFNs. In contrast, we observed 
robust upregulation of Ifna4 and Ifnb mRNAs in response to L. pneumophila ΔflaA 
infection (Figures 2.7A and 2.7B). However, it is possible that undetectable but 
biologically active amounts of type I IFNs are still produced during infection. 
Alternatively, it is possible that C. burnetii may induce expression of one of the other nine 
known type I IFNs. We therefore used a bioassay that detects type I IFN antiviral activity 
by measuring the ability of supernatants from C. burnetii-infected BMDMs to inhibit 
replication of GFP-expressing Newcastle disease virus (NDV) in mouse fibroblasts (Park 
et al., 2003). As expected, supernatants from BMDMs treated with the TLR3 ligand 
poly(I:C) or L. pneumophila ΔflaA-infected macrophages, which both induce robust type I 
IFN production, markedly decreased viral replication as measured by decreased GFP 
intensity compared to mock-treated cells, confirming that these two stimuli induce IFN 
production (Figures 2.7C and 2.7D). Supernatants from C. burnetii NMII-infected 
BMDMs also led to decreased viral replication, although to a lesser degree, suggesting 
that low, biologically active levels of type I IFN are produced during C. burnetii infection. 
Since type I IFN signaling restricts the intracellular replication of L. pneumophila in 
BMDMs (Coers et al., 2007), we next tested if type I IFN signaling played a similar role in 
the restriction of C. burnetii by measuring replication of WT C. burnetii in B6 or Ifnar-/- 
BMDMs, as all type I IFNs signal through the type I IFN receptor (IFNAR) (Müller et al., 
1994) . IFNAR-deficient BMDMs did not exhibit increased C. burnetii replication by day 7 
post-infection (Figure 2.7E). These data demonstrate that C. burnetii does not robustly 
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induce production of type I IFNs, nor are type I IFNs required to restrict intracellular C. 
burnetii replication in B6 BMDMs. 
 
Discussion 
    Coxiella burnetii can infect and replicate within macrophages, yet little is known about 
the immune mechanisms utilized by macrophages to detect and restrict intracellular C. 
burnetii replication. In our study, we aimed to identify innate immune pathways used by 
B6 macrophages to detect and restrict C. burnetii NMII. B6 macrophages are not 
permissive for intracellular C. burnetii growth (Zamboni et al., 2004), despite the ability of 
C. burnetii to translocate T4SS effectors into these cells (Newton et al., 2013). Past 
studies identified a critical role for TLR2 in enabling B6 macrophages to detect and limit 
C. burnetii replication (Zamboni et al., 2004), suggesting that innate immunity plays a 
key role in controlling C. burnetii infection in this cell type. However, the roles of other 
TLRs and the signaling adaptors MyD88 and Trif in the innate immune response to C. 
burnetii remain poorly understood. Here, we find that TLR2 and TLR4 signal in concert to 
mediate proinflammatory cytokine production in response to C. burnetii NMII. The TLR 
signaling adaptors MyD88 and Trif were required for this cytokine response and also 
contributed to the restriction of C. burnetii replication. Furthermore, to date, whether 
cytosolic immunosurveillance pathways detect bacterial products translocated by the C. 
burnetii T4SS and limit C. burnetii growth in B6 macrophages is unclear. In this study, 
we find that C. burnetii does not induce inflammasome activation or robust production of 
proinflammatory cytokines or type I IFNs in a T4SS-dependent manner, suggesting that 
C. burnetii does not robustly activate cytosolic immune sensing pathways in B6 
macrophages.  
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    We first set out to examine the role of TLR signaling in pro-inflammatory cytokine 
production and bacterial restriction in B6 BMDMs infected with C. burnetii NMII. In 
agreement with previous findings (Zamboni et al., 2004), we found production of TNF 
and IL-6 to be largely mediated by TLR2. Interestingly, we also uncovered a role for 
TLR4 in the production of these cytokines. Deletion of TLR4 alone did not impact 
cytokine production, consistent with previous findings, but concomitant ablation of TLR2 
and TLR4 yielded a significant decrease in cytokine production greater than that 
observed with TLR2 deficiency alone. Consistent with a role for both TLR2 and TLR4 in 
immune sensing of C. burnetii NMII, we found that the adaptor proteins MyD88, which 
signals downstream of both TLR2 and TLR4, and Trif, which signals downstream of 
TLR4, are both required for cytokine production and restriction of bacterial replication in 
infected macrophages. As we were able to uncover a role for TLR4 alone in the absence 
of TLR2, this suggests that TLR4 is not essential for responding to C. burnetii, consistent 
with previous findings showing that C. burnetii LPS is not stimulatory for TLR4 (Zamboni 
et al., 2004). However, it is possible in the context of the whole bacterium, TLR4 
somehow responds to C. burnetii, either by sensing lipid A or another PAMP, but that 
TLR2 plays a more major role in sensing C. burnetii. As virulent phase I C. burnetii, in 
contrast to avirulent phase II C. burnetii, inhibits p38 MAPK signaling in a TLR4-
dependent manner (Barry et al., 2012), further studies are necessary to test if TLR2 and 
TLR4 act in concert to respond to phase I C. burnetii as well. These studies could 
provide important insight into whether full-length LPS is an evasion strategy used by 
phase I C. burnetii to limit TLR detection. Furthermore, we found a dominant role for TLR 
signaling in mediating p38 MAPK activation in response to C. burnetii NMII infection. 
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These results show that production of cytokines in response to C. burnetii infection is 
highly dependent on TLR sensing. 
    TLRs detect extracellular PAMPs at the cell surface and within endosomes (Akira, 
2003; Janeway, 1989; Janeway and Medzhitov, 2002; Medzhitov, 2007). Therefore, to 
mount an immune response tailored against intracellular bacterial pathogens (Fritz et al., 
2006; Inohara et al., 2005; Ting et al., 2006), the immune system often relies on 
cytosolic PRRs that respond to bacterial products introduced into the host cytosol by 
many intracellular bacterial pathogens. Studies on the evolutionarily related pathogen L. 
pneumophila have shown that its Dot/Icm T4SS is required for translocation of bacterial 
effectors into the host cell cytosol and bacterial survival within macrophages, but also 
inadvertently exposes L. pneumophila to an array of cytosolic immunosurveillance 
pathways. Infection with WT L. pneumophila expressing a functional T4SS significantly 
increases the production of TNF, IL-6, and IL-12 and robustly activates host MAPK 
signaling, type I IFN production, and several inflammasome pathways compared to 
avirulent L. pneumophila mutants lacking a functional T4SS (Casson et al., 2013; Shin et 
al., 2008). Several of these pathways restrict intracellular L. pneumophila replication. 
Coxiella burnetii uses a closely related Dot/Icm T4SS to translocate effector proteins into 
the host cell cytosol, and C. burnetii NMII can translocate T4SS effectors into B6 
BMDMs. Thus, we next asked whether cytosolic immunosurveillance pathways respond 
to C. burnetii T4SS activity and restrict bacterial replication in B6 BMDMs (Newton et al., 
2013). In contrast to what we observed for L. pneumophila, we did not observe a clear 
requirement for the C. burnetii T4SS in the cytokine response. Instead, we observed a 
slight decrease in TNF and IL-6 production in response to T4SS-sufficient C. burnetii 
compared to a T4SS-mutant strain. While the difference was not robust, it suggests the 
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intriguing possibility that C. burnetii T4SS effectors inhibit cytokine production. 
Inflammasomes are another cytosolic immune response that are robustly activated and 
play a critical role in controlling a variety of pathogens, including L. pneumophila 
(Casson and Shin, 2013). Unlike L. pneumophila, C. burnetii does not possess flagellin 
(Seshadri et al., 2003), a potent activator of the NAIP5 inflammasome (Casson et al., 
2013). It is unknown, however, if C. burnetii possesses other stimulators of 
inflammasome activation, as is the case for L. pneumophila. We found that while C. 
burnetii induces pro-IL-1β production, it does not induce inflammasome activation. This 
could be because C. burnetii does not express PAMPs that are recognized by 
inflammasome-associated PRRs. For example, caspase-11 recognizes hexa- or penta-
acylated LPS, but C. burnetii generates tetra-acylated LPS (Zamboni et al., 2004), which 
would not be expected to activate caspase-11 (Hagar et al., 2013). Alternatively, C. 
burnetii may encode T4SS effectors that actively inhibit inflammasome activation. It has 
been shown, however, that primary human alveolar macrophages produce mature IL-1β 
in response to C. burnetii NMII, but not phase I C. burnetii, suggesting that immune 
sensing pathways in mouse and human cells may respond differently to NMII C. burnetii 
(Graham et al., 2013). Our findings that C. burnetii does not robustly induce 
inflammasome activation in mouse cells may provide some insight into the observation 
that C. burnetii does not elicit robust neutrophil recruitment during in vivo infection of 
mice (Elliott et al., 2013), as inflammasome-derived IL-1 is a critical regulator of 
neutrophil recruitment during pulmonary L. pneumophila infection (Barry et al., 2013; 
Casson et al., 2013; LeibundGut-Landmann et al., 2011; Mascarenhas et al., 2015). Our 
findings raise the intriguing possibility that C. burnetii has evolved strategies to evade or 
actively inhibit cytosolic innate immune detection. 
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    Many intracellular bacteria induce cytosolic immunosurveillance pathways that lead to 
type I IFN expression, and this response can be both beneficial to the host by limiting 
intracellular bacterial replication, as is the case for L. pneumophila (Schiavoni et al., 
2004), or detrimental to the host, as is the case for M. tuberculosis (Manzanillo et al., 
2012), by promoting intracellular bacterial replication. It is unknown, however, if type I 
IFNs are induced or play a role in controlling C. burnetii infection. Our studies indicate 
that C. burnetii infection induces very low, but biologically active levels of type I IFNs. 
Furthermore, we found that BMDMs lacking the type I IFN receptor did not exhibit 
increased bacterial replication, suggesting that type I IFNs do not participate in restricting 
C. burnetii replication in B6 macrophages. 
     As our studies suggested a more prominent role for TLRs rather than cytosolic 
immune sensing pathways in responding to C. burnetii, we next examined the 
mechanistic basis underlying the link between TLR recognition and control of bacterial 
replication. Given that our data and other published studies demonstrated a critical role 
for TLR signaling in mediating production of proinflammatory cytokines during C. burnetii 
infection, we wondered whether cytokines play a role in restricting C. burnetii replication. 
Interestingly, BMDMs lacking only Trif did not have a defect in limiting intracellular C. 
burnetii replication despite having a defect in TNF production, whereas MyD88-deficient 
BMDMs had a defect in both TNF production and control of C. burnetii replication that 
resembles Tlr2-/- BMDMs. We were able to uncover a role for Trif in limiting replication of 
C. burnetii only when we deleted both Trif and MyD88, which led to increased bacterial 
replication compared to deletion of MyD88 alone. These findings suggest that in addition 
to TNF production, TLR2 and MyD88 signaling are required for other antibacterial 
effector mechanisms that restrict C. burnetii.  
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    In conclusion, our findings highlight the importance of TLR signaling in enabling B6 
macrophages to restrict C. burnetii NMII. Our data also indicate that C. burnetii NMII 
T4SS activity does not robustly trigger several cytosolic immunosurveillance pathways 
that we examined, nor do these pathways play a major role in the control of intracellular 
C. burnetii replication in B6 macrophages. Our studies provide further insight into innate 
immune pathways used by macrophages to sense and restrict the replication of this 
poorly understood pathogen. 
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Figure 2.1 TLR2 and TLR4 mediate immune responses to Coxiella burnetii in 
mouse macrophages (A and B) C57BL/6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- bone marrow-
derived macrophages (BMDMs) were infected with WT C. burnetii NMII at MOI=5 or 50 
for 24 hours. Levels of TNF and IL-6 in the supernatants were measured by ELISA. 
Graphs show the mean ± SEM of triplicate wells. Representative of three independent 
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experiments. (C) C57BL/6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- BMDMs were infected with WT 
C. burnetii NMII at MOI=100. At days 1 and 7 post-infection, bacterial uptake and 
replication was measured as genomic equivalents (GEs) by qPCR. Graphs show the fold 
change in GEs on day 7 relative to GEs on day 1 ± SEM of triplicate wells. (D) 7 days 
post-infection, BMDMs of the indicated genotypes infected with mCherry-expressing WT 
C. burnetii NMII at MOI=100 were fixed, stained with DAPI, and examined by 
fluorescence microscopy. The number of mCherry-expressing C. burnetii-containing 
vacuoles was enumerated and calculated as a percentage of the total cell number. 
Graphs show the mean percentage of cells containing C. burnetii vacuoles ± SEM of 
triplicate coverslips. At least 300 cells were counted per coverslip. Representative of two 
independent experiments. (E) Representative fluorescence micrographs of mouse 
BMDMs of the indicated genotypes infected with mCherry-expressing C. burnetii (Cb) at 
MOI=100 and fixed and stained with DAPI on day 7 post-infection. Images were taken at 
40X magnification. Scale bars represent 25 µM. *p<0.05, **p<0.01, ***p<0.001, ns=no 
significance.  
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Figure 2.2 Myd88 and Trif are required for cytokine production and the restriction 
of intracellular growth (A and B) C57BL/6, Trif-/-, Myd88-/-, and Myd88-/-Trif-/- BMDMs 
were infected with WT C. burnetii NMII at MOIs= 5 and 50 for 24 hours. Levels of TNF 
and IL-6 in the supernatants were measured by ELISA. Graphs show the mean ± SEM 
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of triplicate wells. Representative of two independent experiments (C) C57BL/6, Trif-/-, 
Myd88-/-, and Myd88-/-Trif-/- BMDMs were infected with WT C. burnetii NMII at MOI=100. 
At days 1 and 7 post-infection, bacterial uptake and replication was measured as 
genomic equivalents (GEs) by qPCR. Graphs show the fold change in GEs relative to 
the GEs measured on day 1 ± SEM of triplicate wells. (D) ) 7 days post-infection, 
BMDMs of the indicated genotypes infected with mCherry-expressing WT C. burnetii 
NMII at MOI=100 were fixed, stained with DAPI, and examined by fluorescence 
microscopy. The number of C. burnetii-containing vacuoles was enumerated and 
calculated as a percentage of the total cell number on day 7 post-infection. Graphs show 
the mean percentage of cells containing C. burnetii vacuoles ± SEM of triplicate 
coverslips. At least 300 cells were counted per coverslip. Representative of two 
independent experiments. (E) Representative fluorescence micrographs of BMDMs of 
the indicated genotypes infected with mCherry-expressing C. burnetii (Cb) at MOI=100 
and fixed and stained with DAPI on day 7 post-infection. Images were taken at 40X 
magnification. Scale bars represent 25 µM. *p<0.05, **p<0.01, ***p<0.001, ns=no 
significance. 
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Figure 2.3 Purified C. burnetii LPS does not induce TNF production. C57BL/6 
BMDMs were pre-treated for various concentrations of purified C. burnetii Nine Mile 
phase II LPS (Cb) for 30 min then treated with various concentrations of E. coli LPS for 
24 hours. TNF was measured by ELISA. Graphs represent means of triplicate wells. 
Experiment is representative of two experiments. *p<0.05 
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Figure 2.4 C. burnetii’s T4SS is capable of injecting effectors into C57BL/6 BMDMs 
C57BL/6 BMDMs were treated with RPMI or infected, and ΔflaA and ΔdotA strains 
expressing BlaM-RalF MOI=5, or with WT and icmL::Tn expressing BlaM-CBU_0077 at 
MOI= 5, 50 and 100. 16 hours post infection Cells were then loaded with CCF4-AM and 
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analyzed by flow cytometry. Cells positive for cleaved CCF4-AM (blue) fluorescence 
were gated and the percentage injection is denoted in each gate. Experiment is 
representative of two experiments. 
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Figure 2.5 C. burnetii T4SS expression does not lead to enhanced cytokine 
production or early p38 MAPK phosphorylation. (A and B) C57BL/6 BMDMs were 
infected with L. pneumophila (Lp) ΔflaA or ΔdotA at MOI=5, or WT C. burnetii (Cb) or 
icmL::Tn at MOI=5 or 50 for 24 hours. Levels of (A) TNF and (B) IL-6 in the supernatants 
were measured by ELISA. Graphs show the mean ± SEM of triplicate wells. 
Representative of three independent experiments.(C and D) C57BL/6 BMDMs and Tlr2-/- 
were infected with WT C. burnetii (Cb) or icmL::Tn at MOI= 50 for 24 hours. Levels of (C) 
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TNF and (D) IL-6 in the supernatants were measured by ELISA. Graphs show the mean 
± SEM of triplicate wells. Representative of two independent experiments (E) 
Immunoblot analysis of phosphorylated and total p38 MAPK in cell lysates from C57BL/6 
and Myd88-/- BMDMs that were mock-infected or infected with WT C. burnetii NMII at 
MOI=50 for 0, 15, 30, or 120 minutes. Representative of two independent experiments. 
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Figure 2.6 Coxiella burnetii infection does not induce detectable inflammasome 
activation. (A and B) Unprimed C57BL/6 BMDMs were mock-infected, infected with L. 
pneumophila ΔflaA at MOI=5, or infected with WT C. burnetii NMII at MOI= 20, 50, or 
100 for 24 hours. Levels of (A) IL-1α and (B) IL-1β were measured in the supernatants 
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by ELISA. Graphs show the mean ± SEM of triplicate wells. Representative of three 
independent experiments. (C) C57BL/6 BMDMs were treated with 0.5 ug/mL LPS for 4 
hours followed by 2.5mM ATP for one hour or infected with WT C. burnetii NMII at 
MOI=50 for 24 hours. % cytotoxicity was measured via LDH release. Graph shows the 
mean ± SEM of triplicate wells. (D and E) C57BL/6 BMDMs were first primed with 0.5 
ug/mL LPS for 4 hours and then either mock-infected, infected with L.  pneumophila 
ΔflaA at MOI=5, or infected with WT C. burnetii at MOIs=20, 50, 100 for 24 hours. Levels 
of (D) IL-1α and (E) IL-1β were measured in the supernatants by ELISA. Graphs show 
the mean ± SEM of triplicate wells. Representative of two independent experiments. (F) 
C57BL/6, Tlr2-/-, and Casp1-/-Casp11-/- BMDMs were infected with WT NMII C. burnetii at 
MOI=100. At days 1 and 7 post-infection, bacterial uptake and replication was measured 
as genomic equivalents (GEs) by qPCR. Graphs show the fold change in GEs on day 7 
relative to GEs on day 1 ± SEM of triplicate wells. (G) Immunoblot analysis of pro-IL-1β 
and actin in cell lysates from unprimed C57BL/6 BMDMs that were mock-infected or 
infected with L. pneumophila ΔflaA or ΔdotA at MOI=5, or WT C. burnetii or icmL::Tn at 
MOI=20, 50, or 100 for 24 hours. Representative of two independent experiments. 
(H) Immunoblot analysis of processed caspase-1 (casp-1 p10) in the supernatant of 
primed C57BL/6 BMDMs and pro-IL-1β and actin in the cell lysate. Representative of 
two independent experiments.  
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Figure 2.7 Coxiella burnetii infection does not induce robust type I interferon 
production and intracellular replication is not restricted by type I interferon 
signaling. (A and B) C57BL/6 BMDMs were mock-infected, infected with L. 
pneumophila ΔflaA at MOI=10, or infected with WT C. burnetii NMII at MOI=10, 50, or 
100 for 16 hours. Fold-induction of Ifna4 and Ifnb mRNAs were measured via qRT-PCR. 
Graphs show the mean ± SEM of triplicate wells. Representative of two independent 
experiments. (C) Supernatants from C57BL/6 BMDMs that were mock-infected, infected 
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with L. pneumophila ΔflaA at MOI=10, or infected with WT C. burnetii NMII at MOI=50 
for 16 hours were incubated with L2 mouse fibroblasts for 24 h. L2 cells were then 
infected with NDV-GFP at an MOI=1. As a positive control, L2 cells were treated with 
supernatants from C57BL/6 BMDMs stimulated with poly (I:C) for 16 hours. At 24 hours 
post-infection, cells were fixed, stained with DAPI, and examined for levels of NDV-GFP 
replication by fluorescence microscopy. Shown are representative fluorescence 
micrographs. (D) Graphs of mean GFP fluorescence from each sample quantified with 
ImageJ software. Representative of two independent experiments. (E) C57BL/6, Ifnar-/-, 
or Myd88-/-Trif-/- BMDMs were infected with WT C. burnetii NMII at MOI=100. C. burnetii 
GEs were measured qPCR on days 1 and 7 post-infection. Graphs show the fold change 
in GEs relative to day 1 ± SEM of triplicate wells. Representative of two independent 
experiments. 
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Figure 2.8.  Levels of internalized WT Coxiella burnetii are similar for different 
genotypes of bone marrow-derived macrophages at 24 hours post-infection. 24 
hours post-infection, the number of internalized WT C. burnetii NMII genomic equivalents 
(GEs) were measured by qPCR for (A) C57BL/6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- BMDMs 
presented in Figure 2.1C,  (B) C57BL/6, Trif-/-, Myd88-/-, and Myd88-/-Trif-/- BMDMs 
presented in Figure 2.2C, (C) C57BL/6, Tlr2-/-, and Casp1-/-Casp11-/- BMDMs presented 
in Figure 2.6F, and (D) C57BL/6, Ifnar-/-, MyD88-/-Trif-/-  BMDMs presented in Figure 
2.7E. 
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Abstract 
 
Pathogen activation of surface and cytosolic sensors triggers a variety of innate immune 
responses. Our studies described in the previous chapter have shown that Coxiella 
burnetii does not robustly activate cytosolic production of pro-inflammatory cytokines, nor 
does it activate the inflammasome. Instead, the innate immune response to C. burnetii 
relied largely on TLR-mediated detection, with TLR2 playing the dominant role in the 
production of pro-inflammatory cytokines and cell-intrinsic control of C. burnetii 
replication in vitro. Building upon these observations, we were further able to implicate 
TNF as a mediator of cell-intrinsic control of bacterial replication, as TNF-deficient 
macrophages were permissive for C. burnetii replication. Furthermore, we found that 
soluble TNF is able to restrict C. burnetii replication in Tlr2-/- macrophages. To elucidate 
the mechanism by which TNF mediates cell-intrinsic control of C. burnetii replication, we 
tested three possible TNF-mediated bacterial restriction mechanisms: cell death, 
production of ROS and RNS, and Guanylate Binding Proteins (GBPs). We found that C. 
burnetii does not induce robust cell death, indicating that TNF-induced extrinsic 
apoptosis and programmed necrosis are not major control mechanisms. We found C. 
burnetii induces RNS in a TNF-dependent manner. C. burnetii also induces whole cell 
ROS, which plays a role in restricting bacterial replication. GBP1 and GBP2 are induced 
by C. burnetii infection, but we did not find a role for these or three additional GBPs in 
bacterial restriction.  Overall, these findings implicates the cytokine TNF, which is 
induced by C. burnetii in a TLR-dependent manner, as mediating restriction of C. burnetii 
replication and further examines possible mechanisms of TNF-mediated restriction. 
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Introduction 
 
    The downstream consequences of cell surface and cytosolic immune detection are 
critical for successful pathogen clearance. Following pathogen activation of cell surface 
and cytosolic immune sensors, immune cells release a set of cytokines and chemokines. 
These cytokines and chemokines, in turn, can signal to other cells to induce an cell-
extrinsic immune response or signal back to the compromised cell to induce an cell-
intrinsic immune response (Kawai and Akira, 2009). 
    Tumor necrosis factor (TNF) is a well-studied cytokine that is expressed in response 
to a wide array of pathogens (Akira, 2003). In the context of bacterial infection, PAMPs 
stimulate TLR and cytosolic immune receptors to activate the NF-κB and MAPK 
signaling pathways to induce the transcription of TNF (Akira, 2003), with macrophages 
thought to be a major source of TNF (Wajant et al., 2003). TNF is expressed as a type II 
transmembrane protein that arranges into homotrimers (Kriegler et al., 1988; Tang et al., 
1996). The soluble form is released via proteolytic cleavage by the metalloprotease TNF 
alpha-converting enzyme (TACE) (Black et al., 1997). Two TNF receptor (TNF-R) family 
members, TNF-R1 and TNF-R2, bind soluble and membrane-bound TNF and induce a 
variety of cell-intrinsic and cell-extrinsic immune responses (Locksley et al., 2001). While 
membrane-bound TNF strongly binds both TNF-R1 and TNF-R2 receptors, soluble TNF 
preferentially signals thought TNF-R1 (Grell et al., 1995; Wallach et al., 1991). TNF-R1 is 
ubiquitously expressed on most cell types, and TNF-R2 is only expressed on immune 
cells (Locksley et al., 2001). The activity of TNF is broad and it has been found to play a 
major role in pathogen and tumor clearance (Wajant et al., 2003). Overproduction or 
prolonged production of TNF can drive pathological inflammation leading to septic shock 
or a number of autoimmune pathologies including rheumatoid arthritis and inflammatory 
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bowel disease (Blam et al., 2001; Taylor et al., 2000). Several anti-TNF therapies have 
been developed to decrease TNF-dependent autoimmune inflammation (Taylor, 2001). 
These therapies have proven effective at alleviating the symptoms of many autoimmune 
diseases, but have also been linked to increased susceptibility to certain pathogens, 
notably M. tuberculosis and L. pneumophila (Lanternier et al., 2013; Wagner et al., 
2002). This recent phenomenon highlights TNF’s importance in protection against 
intracellular bacteria. 
    TNF induces a host of cell-intrinsic immune responses that aid in the clearance of 
pathogens, including but not limited to: apoptotic and necroptotic cell death (Schulze-
Osthoff et al., 1998; Tartaglia et al., 1993); induction of reactive oxygen (ROS) and 
reactive nitrogen (RNS) species (Chakravortty and Hensel, 2003; Han et al., 2009); and 
the induction of guanylate binding proteins (GBPs) (Vestal and Jeyaratnam, 2011). TNF-
induced cell death occurs in two forms: caspase-8 mediated extrinsic apoptosis and 
caspase-independent programmed necrosis. TNF binding alone induces pro-survival 
cascades which upregulate anti-apoptotic proteins, such as c-FLIP (Wajant et al., 2003). 
c-FLIP shares sequence homology with the death caspase, caspase-8, but lacks a 
catalytic domain. It binds caspase-8 to prevent caspase-8::caspase-8 homodimerization 
and subsequent activation (Micheau and Tschopp, 2003; Schulze-Osthoff et al., 1998). 
When host protein synthesis disrupted and c-FLIP is not upregulated, TNF signaling 
induces caspase-8 activation. Active caspase-8 leads to the processing and activation of 
the terminal death caspase, caspase-3, which initiates DNA fragmentation, membrane 
blebbing, and cell death. Caspase-8 can activate caspase-3 via direct processing or 
through the mitochondrial pathway, whereby cytochrome C released from permeabilized 
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mitochondria activates caspase-9, which then activates caspase-3 to initiate cell death 
(Micheau and Tschopp, 2003). 
    Programmed necrosis, or necroptosis, occurs as a backup when extrinsic apoptosis is 
inhibited by viral inhibitors such as vICA and CrmA (Ray and Pickup, 1996; Skaletskaya 
et al., 2001). Necroptosis can be induced by TNF, Toll-like receptors (TLR3 and TLR4), 
or DNA sensors (DAI) (Vandenabeele et al., 2010). When caspase-8 activation is 
inhibited, TNF bound to TNFR-1 is internalized and initiates the assembly of a RIPK1-
RIPK3 complex, termed the necrosome. In this complex, both RIPK1 and RIPK3 are 
phosphorylated and initiate a series of necroptotic events that lead to cell death and the 
release of alarmins, such as IL-1α, IL-33, and Danger Associated Molecular Patters 
(DAMPs), such as heat shock proteins and ATP (Vandenabeele et al., 2010). DAMPs 
have the potential to trigger surface and cytosolic immune receptors as well. Both 
apoptosis and necroptosis are thought to control intracellular pathogens by eliminating 
their replicative niche. 
     TNF also has the potential to induce ROS and RNS, which have a broad spectrum of 
anti-microbial activities (Wajant et al., 2003). ROS is generated by the constitutively 
expressed NADPH phagocytic oxidase (Phox), while RNS is generated by inducible nitric 
oxide synthase (iNOS) (Bylund et al., 2010; Nathan and Shiloh, 2000). The formation of 
the phox complex produces oxygen radicals via electron transfer, which in turn 
spontaneously generate hydrogen peroxide intermediates. Highly toxic hydroxyl radicals 
and hypochlorous acid are further generated via the Fenton reaction or by cellular 
myeloperoxidase (MPO) (Imlay and Linn, 1988; Imlay, 2008; Tlili et al., 2011). These 
reactive oxygen intermediates likely target bacterial DNA and can also act as signaling 
molecules to induce production of inflammatory cytokines and cell death. RNS 
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production requires the de novo synthesis of inducible nitric oxide synthase (iNOS), 
which contains a N-terminal oxygenase and a C-terminal reductase. Upon expression, 
iNOS forms homodimers and localizes to the phagosome in an actin-dependent manner 
to synthesize nitric oxide radicals from L-arginine substrate (Albakri and Stuehr, 1996; 
Baek et al., 1993; Davis et al., 2007). Nitrogen radicals target a variety of bacterial 
components, including bacterial DNA, proteins, and lipids. Bacterial death and replication 
inhibition results primarily via disruption of components of the bacterial respiration 
pathway (Nathan and Shiloh, 2000). 
    Guanylate binding proteins (GBPs) are additional cell-intrinsic immune effectors that 
can be activated by TNF (Martens and Howard, 2006). Mice encode 11 GBPs (mGBP-1 
to mGBP11), while humans encode 7 GBPs (hGBP-1 to hGBP-7) (Olszewski et al., 
2006). GBPs are classically thought to be induced by Type I and Type II interferons, but 
select GBPs have been shown to be induced by IL-1α, IL-1β and TNF (Vestal and 
Jeyaratnam, 2011). Upregulated GBPs are targeted to cellular membranes by 
isoprenylation, which involves the addition of a C-15 farnesyl or C-20 geranylgeranyl lipid 
moieties to the cysteine residue in the conserved, C-terminal CaaX sequence (Vestal 
and Jeyaratnam, 2011). Both mice and human GBPs have been implicated in the control 
of intracellular pathogens (Nguyen et al., 2002).For example, hGBP-1 and hGBP-2 
inhibit replication of Chlamydia spp (Tietzel et al., 2009); mGBP-2 controls replication of 
Toxoplasma gondii (Degrandi et al., 2013); and mGBP-5 promotes Salmonella 
Typhimurium-induced pyroptosis (Pilla et al., 2014). 
     C. burnetii has evolved strategies to subvert some of these pathways. It is well-
characterized that C. burnetii inhibits artificially induced intrinsic apoptosis through the 
T4SS effectors AnkG, CaeA, and CaeB (Klingenbeck et al., 2013; Lührmann et al., 
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2010). To date, only one study has offered insight into TNF-mediated extrinsic apoptosis. 
In that study, THP-1 cells infected with C. burnetii were treated with recombinant TNF 
and cyclohexamide and reduced cleavage of PARP, a terminal marker of apoptosis, was 
observed (Voth et al., 2007). This study, however, did not link this inhibition to a 
functional T4SS, nor did it show C. burnetii has the potential to induce caspase-8 
mediated apoptosis occurs. Another study also found that at a relatively early time point, 
24 hours post-infection, C. burnetii induces a caspase-independent form of cell death 
that is partially mediated by TNF (Zhang et al., 2012). These studies offer the possibility 
of both apoptotic and necroptotic cell death as mechanisms to control C. burnetii or 
pathways that are evaded by C. burnetii.    
    Studies on the role and significance that ROS and RNS play in the restriction of C. 
burnetii have varying conclusions.  Some studies concluded that C. burnetii does not 
elicit a detectible oxidative burst in monocytes and therefore does not produce either 
ROS or RNS in human neutrophils or macrophages (Akporiaye et al., 1990; 
Dellacasagrande et al., 1999). Moreover, C. burnetii growth did not differ between 
monocytes from healthy human donors and those with chronic granulomatous disease, 
which lack a functional NADPH (Akporiaye et al., 1990). Other studies with macrophages 
treated with exogenous IFNγ showed C. burnetii infection did induce both ROS and 
RNS, which were both shown to play a role in growth restriction upon stimulation in the 
presence of exogenous IFNγ (Brennan et al., 2004; Zamboni and Rabinovitch, 2003). 
Like many pathogens, C. burnetii has evolved strategies to combat ROS and RNS 
stress. It was shown that phagocytosis of C. burnetii by neutrophils prevented assembly 
of the NADPH oxidase on the phagosomal membrane via an unknown mechanism, 
reducing whole cell levels of ROS (Siemsen et al., 2009). It was also demonstrated that 
	  
	   80 
C. burnetii secretes an acid phosphatase into the vacuole that reduces neutrophil ROS 
(Hill and Samuel, 2011). This C. burnetii enzyme may prevent the phosphorylation of an 
NADPH component. However, the role of ROS and RNS in the context of C. burnetii 
infection of macrophages and endogenously produced TNF remain poorly understood. 
     The role of GBPs in C. burnetii infection have not been studied. Because C. burnetii 
forms a large vacuole that acquires membrane from a variety of sources and fusion 
events, it is likely that GBPs are recruited to the vacuole in some capacity. Whether 
infection with C. burnetii induces the expression of these GBPs or if these proteins 
promote or inhibit bacterial replication is unknown. 
     In this study, we found a role for soluble TNF in the cell-intrinsic inhibition of C. 
burnetii Nine Mile phase II replication within B6 macrophages. We previously showed 
that C. burnetii does not induce cytosolic-mediated immune responses, nor Type I 
interferon. We did find a role for TLR-dependent restriction mediated by both adaptors 
Myd88 and Trif and implicated both TLR2 and TLR4 in the production of TNF. Building 
upon this, we found TNF plays a critical role in in vitro control of C. burnetii infection. We 
then analyzed three possible cell-intrinsic effector pathways by which TNF could be 
restricting bacterial replication: cell death, ROS and RNS, and GBP induction. 
 
Materials and Methods 
 
Bacteria Strains 
All experiments in this study used Coxiella burnetii Nine Mile Phase II (clone 4; RSA 
439). For C. burnetii infections, acidified citrate cysteine medium (ACCM-2) was 
inoculated with WT C. burnetii (Omsland et al., 2013) or WT C. burnetii expressing 
mCherry (Beare et al., 2009). C. burnetii was grown at 37°C in 5% CO2 and 2.5% O2 for 
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6 days to late log phase (~1.0x109 bacteria/mL) (Omsland et al., 2013). One day after 
inoculation, chloramphenicol (2.5 μg/mL) was added to mCherry cultures. To quantify C. 
burnetii genome equivalents for infection of macrophages, C. burnetii genomic DNA was 
isolated with the illustraTM bacteria genomicPrep Mini Spin Kit (GE Healthcare), and 
genomic equivalents were measured by quantitative PCR of the C. burnetii dotA gene 
using SYBR Green, the CFX96 qPCR machine (Bio-Rad Laboratories), and the following 
primers: dotA 5’ (GCGCAATACGCTCAATCACA), dotA 3’ (CCATGGCCCCAATTCTCT).  
 
Mammalian Cell Culture 
Bone marrow was isolated from the femurs, tibia, and humeri of C57BL/6 (Jackson), 
Tlr2-/-, Tnf-/- (Pasparakis et al., 1996), GBPChrm3-/- (Yamamoto et al., 2003), and gp91phox-
/- (Pollock et al., 1995) mice. Bone marrow cells were differentiated into macrophages for 
7-8 days in RPMI containing 30% L929 cell supernatant and 20% FBS at 37°C in a 
humidified incubator (Casson et al., 2013). Macrophages were lifted with ice-cold PBS + 
2 mM EDTA and replated one day prior to infection in RPMI containing 15% L929 cell 
supernatant and 10% FBS. Macrophages were plated into 96, 48 or 24 well plates at 
1.0x105, 1.5x105 or 2.0x105 cells per well, respectively. C. burnetii were washed once 
with PBS prior to infection of macrophages, and macrophages were infected with various 
MOIs of C. burnetii. C. burnetii were washed once with PBS prior to infection of 
macrophages. After infection, cells were spun at 1200 RPM for 5 minutes prior to 
incubation at 37˚C. At designated timepoints, macrophage supernatants, whole cell 
lysates, or mRNA were collected. 
 
Measuring Intracellular Coxiella burnetii Replication 
	  
	   82 
Measuring intracellular replication of C. burnetii in C57BL/6, Tlr2-/-, Tnf-/-, GBPChrm3-/-, and 
gp91phox-/- BMDMs was performed as follows. Macrophages were infected with C. 
burnetii Nine Mile Phase II expressing mCherry at MOI=100 in 24 well plates. 24 hours 
post-infection, cells were washed 3 times with PBS to remove extracellular bacteria and 
fresh media was added to the cells every 2 days. At designated timepoints post-
infection, the extracellular media was collected and the adherent macrophages were 
lysed with 1mL sterile dH2O. The lysed samples were then combined with the 
extracellular media from the same well. Bacterial genomic DNA was purified and C. 
burnetii genomic equivalents (GE) were measured via qPCR using primers specific for 
the C. burnetii dotA gene. The fold change in bacterial GEs was calculated as a ratio of 
the number of GEs on a given day to the number of GEs on day 1. For experiments 
examining the role of TNF in restricting C. burnetii growth, 10ng/mL recombinant mouse 
TNF (Biolegend) or supernatants from B6 macrophages infected with C. burnetii for 24 
hours were added to C. burnetii-infected macrophages on day 1 and day 5 post-
infection.  
 
Enumeration of Coxiella burnetii-containing vacuoles by microscopy 
2.0 x 105 cells were plated onto a glass coverslip per well in triplicate in 24 well plates for 
each condition. Seven days post-infection, cells were washed with PBS, stained with 
DAPI, and fixed with 4% paraformaldehyde. Images were taken with a Nikon Eclipse 
2000E-U epifluorescence microscope and images were acquired with NIS Elements B4 
4.10.01 software. Large vacuoles containing mCherry-expressing C. burnetii were 
enumerated as a percentage of total DAPI-positive cells. For each coverslip, greater 
than 300 cells were counted.  
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TUNEL Assay 
2.0 x 105 cells were plated onto a glass coverslip per well in triplicate in 24 well plates for 
each condition. Cells were either mock infected with RPMI, treated with 1000 μM 
staurosporine for 4 hours, or for infected with WT C. burnetii at MOI=100 for 24 hours. 
Post-treatment cells were washed with PBS and fixed with 4% paraformaldehyde. Cells 
were incubated with TUNEL enzyme and TUNEL dye in a humidified incubator for sixty 
minutes. Coverslips were mounted with Prolong-gold with DAPI. Images were taken with 
a Nikon Eclipse 2000E-U epifluorescence microscope and images were acquired with 
NIS Elements B4 4.10.01 software. TUNEL positive cells were enumerated as a 
percentage of total DAPI-positive cells. For each coverslip, greater than 300 cells were 
counted.  
 
Quantitative RT-PCR 
RNA was isolated from infected macrophages using the RNeasy Mini kit and DNase-
treated using the RNase-free Dnase set (Qiagen) to remove contaminating genomic 
DNA. The isolated RNA was then reverse transcribed into cDNA using Superscript II 
reverse transcriptase (Invirogen). Relative mRNA abundance was measured by qPCR 
using SYBR Green and the CFX96 qPCR machine (Bio-Rad Laboratories). The following 
primer pairs were used: Nos2 5’ (ACATCGACCCGTCAACAGTAT), Nos2 3’ 
(CAGAGGGGTAGGCTTGTCTC), mGBP1 5’ (AGATGCCCTTGGTGTGAGAC), mGBP1 
3’ (CTCTACCGCACAGGCAATC), mGBP2 5’ (TCTACCCCACTCTGGTCAGG), mGBP2 
3’ (CAGCATAGGAACCATCAACCA), Hprt 5’ (GTTGGATACAGGCCAGACT), Hprt 3’ 
(GAGGGTAGGCTGGCCTAT).  To calculate relative fold-induction using the ΔΔCT 
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method (Shin et al., 2008), the cycle threshold (Ct) of a given gene was normalized to 
HPRT Ct and compared to the normalized Ct in uninfected cells. 
 
Measurement of Nitric Oxide 
Macrophages were infected at indicated MOIs in 96 well plates at 1.5x105 cells per well 
in 150 uL media. At indicated time points, nitrite (NO2-) levels were measured with the 
Griess reagent system according to the manufacturers guidelines (Promega). 
 
Measurment of Whole Cell ROS 
6.0x105 macrophages were plated in 12-well non-tissue culture plates. Cells were treated 
with 0.5 μg/mL for 6 hours or infected with WT C. burnetii MOI=100 for 16 hours. Cells 
were incubated with 2.5 μM CM-H2DCFDA and HBSS containing Ca, Mg, and glucose 
for 20 min in 37° C for 20 minutes in a humidified incubator. Levels of whole cell ROS 
were measured by flow cytometry. 
 
Statistical Analysis 
The plotting of data and statistical analysis were performed using GraphPad Prism 
software. Statistical significance was determined using unpaired, two-tailed Student’s t 
test or one-way analysis of variance (ANOVA) with Tukey’s posttest. Differences were 
considered significant if the P value was <0.05. 
 
Results 
 
TNF is critical for cell-intrinsic control of Coxiella burnetii Nine Mile phase II 
replication. 
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The addition of exogenous TNF along with IFNγ to a mouse fibroblast cell line or human 
monocytes has been shown to restrict intracellular C. burnetii replication (Ghigo et al., 
2001; Howe et al., 2002). Furthermore, a previous study showed that antibody-mediated 
neutralization of TNF led to increased C. burnetii replication in human monocytes (Howe 
et al., 2002). Whether endogenous levels of TNF produced by B6 BMDMs during 
infection contribute to the restriction of intracellular C. burnetii replication is unknown; 
moreover, it is unknown if TNF alone is sufficient to inhibit intracellular replication in this 
cell type. To test this, we infected Tnf-/- BMDMs with WT C. burnetii and measured 
bacterial uptake (Figure 3.6A), intracellular replication (Figure 3.1A), and vacuole 
formation (Figures 3.1C and 3.1D). We observed robust intracellular bacterial growth in 
Tnf-/- BMDMs, with a greater than 25-fold increase in GE and an increase in C. burnetii-
containing vacuoles by day seven post-infection, suggesting that endogenously 
produced TNF plays a major role in the ability of B6 BMDMs to restrict C. burnetii 
replication. To confirm this restriction was mediated by soluble TNF, we added 10ng/mL 
recombinant TNF to C. burnetii-infected Tnf-/- BMDMs at days 1 and 5 post-infection 
(Figures 3.1B-D). We found that the addition of recombinant TNF restored the ability of 
Tnf-/- BMDMs to restrict C. burnetii replication, as measured by a decrease in GEs and 
the percentage of C. burnetii vacuoles, suggesting that the deficiency in TNF production 
accounts for the increased susceptibility of Tnf-/- BMDMs, and that soluble TNF is 
sufficient to inhibit C. burnetii replication in these cells. Furthermore, the addition of 
supernatants from B6 BMDMs infected with C. burnetii for 24 hours restored the ability of 
Tnf-/- BMDMs to restrict intracellular C. burnetii growth, further supporting that 
intracellular restriction of C. burnetii replication by B6 BMDMs is mediated by secreted 
factor(s), one of which is TNF. Finally, we examined whether the defect in the ability of 
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Tlr2-/- BMDMs to control C. burnetii could be complemented by exogenous treatment 
with rTNF or the supernatants from C. burnetii-infected B6 BMDMs (Figure 3.1E). In 
contrast to mock-treated Tlr2-/- BMDMs, Tlr2-/- macrophages treated with rTNF or 
supernatants from C. burnetii-infected BMDMs were able to restrict intracellular C. 
burnetii replication to levels comparable to B6 BMDMs. Taken together, our data suggest 
that endogenous TNF produced in response to TLR sensing of C. burnetii infection 
critically contributes to the ability of B6 macrophages to control C. burnetii replication. 
Furthermore, these data indicate that the inability of Tlr2-/- BMDMs to control C. burnetii 
replication is primarily due to a defect in TNF production, as addition of exogenous TNF 
restored the ability of these cells to limit intracellular C. burnetii replication. 
 
Coxiella burnetii phase II does not induce cell death in B6 macrophages 
    Cell death is one mechanism by which cells control pathogens. TNF can induce both 
non-inflammatory apoptosis and inflammatory necrosis. One study in THP-1 cells found 
that C. burnetii induces cell death 24 hours post infection (Zhang et al., 2012), while 
another study showed that C. burnetii inhibits extrinsic apoptosis, which is mediated by 
TNF signaling to caspase-8 (Voth et al., 2007). Cell death in B6 BMDMs infected with C. 
burnetii, however, has not been studied. We found no cell death in C. burnetii-infected 
B6 macrophages using the LDH bulk assay at 24 hours post-infection (Figure 2.6C), but 
wanted to test with a more sensitive single cell assay whether cell death was occurring. 
In order to determine if TNF-dependent cell death occurs and is a possible mechanism 
of control for C. burnetii, we employed the TUNEL method of staining. We were unable 
to detect cell death at 24 hours post-infection at an MOI=100, the same MOI used in our 
growth curves (Figure 3.2A and 3.2B). These data, coupled with our previous findings 
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using the LDH cytotoxicity assay (Figure 2.6C), suggest that TNF-mediated cell death is 
not a major mechanism by which B6 macrophages control C. burnetii. 
 
Coxiella burnetii infection induces the production of iNOS and Reactive Nitrogen 
Species (RNS) in B6 macrophages in a TNF-dependent manner 
    Reactive nitrogen species (RNS) are an additional TNF-mediated cell-intrinsic immune 
response. TNF in conjunction with IFNγ have been shown to induce RNS, and this 
induction has been shown to play a role in the clearance of C. burnetii (Howe et al., 
2010). TNF alone, however, has never been implicated in RNS-mediated restriction of C. 
burnetii. Here, we measured induction of iNOS, the protein that synthesizes RNS 
through its substrate L-arginine. We found C. burnetii does induce expression of Inos 
mRNA via qRT-PCR and this expression is partially dependent on endogenously-
produced TNF (Figure 3.3A). We further tested if C. burnetii induced formation of a 
functional NOS2 protein by measuring levels of RNS in the supernatant. C. burnetii 
infection did induce RNS and that induction was partially dependent on endogenous TNF 
(Figure 3.3B). Interestingly, exogenous TNF alone was sufficient to induce high levels of 
Inos transcript, but was not sufficient to induce dimerization and form a functional iNOS 
protein to generate measurable levels of NO2-, indicating that additional stimuli are 
necessary for assembly or functional iNOS proteins. These data demonstrate that RNS 
is generated by C. burnetii in a TNF-dependent manner, offering one potential 
mechanism by which TNF restricts C. burnetii in B6 macrophages. 
 
Coxiella burnetii phase II infection induces ROS, which is a potential mechanism 
of bacterial restriction in B6 macrophages 
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    ROS is another cell-intrinsic control mechanism that can be induced by TNF. Some 
studies show C. burnetii does not induce an oxidative burst, while other studies have 
demonstrated that ROS is produced in response to C. burnetii infection (Akporiaye et al., 
1990; Brennan et al., 2004; Howe et al., 2002). To determine if C. burnetii can induce 
ROS in C57BL/6 macrophages, we infected BMDMs and measured whole cell ROS at 
16 hours post-infection by flow cytometry using the reagent H2DCFDA, which is 
nonfluorescent but is converted to a green-fluorescent form when oxidation by the 
activity of ROS occurs within the cell. We found that C. burnetii does induce measurable 
ROS production (Figure 3.4A). To test if ROS was able to inhibit C. burnetii growth, we 
measured growth in gp91phox-/- macrophages and found significantly increased growth 
in the absence of this component of NADPH oxidase (Figure 3.4B). These data provide 
preliminary evidence for an additional TNF-mediated mechanism by which B6 BMDMs 
restrict C. burnetii replication. 
  
Coxiella burnetii phase II infection induces expression of Guanylate Binding 
Proteins, but they do not play major role in control of bacterial replication 
     Guanylate binding proteins (GBPs) are a class of interferon-inducible GTPases with a 
variety of functions and have been implicated in the control of intracellular pathogens. It 
is known that in conjunction with IFNγ, TNF can induce robust expression of all 11 
murine GBPs (Olszewski et al., 2006; Vestal and Jeyaratnam, 2011; Yamamoto et al., 
2012); however, the role of TNF alone as an inducer of GBP expression remains poorly 
understood. Moreover, a possible role for GBPs in the context of C. burnetii infection has 
not been assessed. Here, we tested the induction of two murine GBPs, mGBP-1 and 
mGBP-2, which have been shown to exhibit antimicrobial properties via delivery of anti-
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microbial products to autolysosomes. We found that the mRNAs encoding mGBP-1 and 
mGBP-2 are induced in B6 BMDMs by TNF alone (Figure 3.5A-B). Furthermore, we 
found that C. burnetii infection induces transcription of these GBPs in a dose-dependent 
manner (Figures 3.5A and 3.5B). To test if these or other GBPs played a role in C. 
burnetii clearance, we measured bacterial replication in GBPChrom3-/- BMDMs (Yamamoto 
et al., 2012), which are deficient in mouse GBPs 1, 2, 3, 5, and 7.  We did not observe 
any difference in bacterial replication in GBP-deficient macrophages (Figure 3.5C), ruling 
out these five GBPs as mediators of C. burnetii restriction.  
 
Discussion 
     Previously we found a major role for the cell surface immune sensors TLR2 and TLR4 
as mediators to restrict C. burnetii replication in B6 BMDMs. We also observed induction 
of pro-inflammatory cytokines to be dependent on TLR2 and TLR4, and rely on both 
Myd88 and Trif adaptor proteins. Since TNF has a known role as a mediator of cell-
intrinsic immunity against other bacterial pathogens, we hypothesized that TNF induces 
multiple cell-intrinsic pathways to restrict C. burnetii replication. In this study, we found 
that TNF has a major role in the restriction of C. burnetii. We further investigated three 
potential mechanisms of TNF-mediated control: (1) cell death; (2) reactive nitrogen 
(RNS) and reactive oxygen (ROS) species; and (3) guanylate-binding proteins (GBPs), 
and preliminarily found a role for ROS in controlling C. burnetii replication. 
     TNF is a pleotropic cytokine that induces a wide array of cell-extrinsic and cell-
intrinsic proinflammatory responses (Grell, 1995; Wajant et al., 2003). Since TNF is a 
major player in inflammation and underlies the pathogenesis of many autoimmune 
diseases, researchers have developed a host of anti-TNF therapies (Taylor, 2001). The 
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widespread use of these therapies has revealed their use leads to higher susceptibility to 
a variety of interacellular pathogens, including M. tubercuolosis and L. pneumophila 
(Jinno et al., 2009; Wagner et al., 2002). In our study we sought to elucidate the cell-
intrinsic mechanism by which TNF inhibits C. burnetii replication in an effort to better 
understand how this broad-acting cytokine restricts intracellular bacterial infection.  
     We first wanted to determine if C. burnetii infection induces these pathways. If 
induced, we then wanted to determine if this induction was dependent on TNF and if the 
pathway played a role in restricting of bacterial replication. We found that C. burnetii 
does induce RNS, ROS, mGBP-1, and mGBP-2 in B6 macrophages, but does not 
induce cell death. We then investigated if TNF induces measurable cell death in B6 
macrophages. TNF can induce both non-inflammatory extrinsic apoptosis and 
inflammatory necrosis (Schulze-Osthoff et al., 1998; Vandenabeele et al., 2010). Both of 
these cell death pathways are thought to control intracellular pathogens by eliminating 
their replicative niche. Programmed necrosis also has the potential to alert neighboring 
immune cells by releasing DAMPs, which stimulate TLRs and cytosolic sensors 
(Pasparakis and Vandenabeele, 2015). In the context of C. burnetii infection, whether 
cell death is induced or whether it is restricts bacterial infection is unclear. A previous 
study demonstrated that C. burnetii inhibits extrinsic apoptosis. In this study, THP-1 cells 
were infected for 48 hours and then treated with TNF and cyclohexamide to artificially 
induce caspase-8-mediated apoptosis (Voth et al., 2007). They found reduced PARP 
cleavage in infected cells compared to uninfected cells. Another study in THP-1 cells 
found that cell death does occur in the first 24 hours of C. burnetii infection. This cell 
death was caspase-3-independent and TNF-dependent (Zhang et al., 2012). This latter 
study suggests that TNF mediated-cell death may be a mechanism of control, whereas 
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the earlier study suggests C. burnetii has evolved strategies to evade these control 
mechanisms. Here, we determined whether B6 macrophages undergo cell death during 
C. burnetii infection. We measured cell death via both the LDH release assay, which 
broadly measures general cell death at the population level, and the TUNEL assay, 
which is primarily used to detect apoptotic cell death at the single cell level. In both 
assays we found no measurable cell death at 24 hours post infection. Since TUNEL 
does not stain well for cells undergoing programmed necrosis (Nonaka et al., 2003), 
these data do not completely rule out necroptosis as an early mechanism of restriction. 
Further studies using propidium iodide staining, which stains both apoptotic and 
necroptotic cells or growth curves in Rip3-/- macrophages are necessary to rule out 
programmed necrosis as a mechanism of C. burnetii control (Nonaka et al., 2003; 
Vandenabeele et al., 2010). Given the LDH bulk assay showed no measurable death, it 
is unlikely that necroptosis is robustly induced, if at all.  
     Our data rule out TNF-mediated apoptosis as a major mechanism of bacterial control 
since we observed that death is not robustly induced during C. burnetii infection. A 
previous study indicated that artificially induced TNF-mediated extrinsic apoptosis is 
inhibited by C. burnetii in human THP-1 cells (Voth et al., 2007), but no direct link to 
bacterial effectors was made. Complete inhibition by the T4SS alone is unlikely given 
that we see no measurable cell death and we would expect that bacterial effector-driven 
inhibition of cell death would not be one hundred percent complete. A more likely reason 
is that, unlike Yersinia spp. or Mycobacterium avium, C. burnetii does not induce 
extrinsic apoptosis or alternatively, C. burnetii induces an anti-apoptotic signaling 
pathway (Fratazzi et al., 1997; Ruckdeschel et al., 1997). Future studies with the T4SS-
deficient strain and the exogenous induction of TNF-mediated apoptosis would 
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determine if C. burnetii is actively inhibiting this pathway. To conclusively determine 
whether this pathway plays a role in the restriction of C. burnetii replication in B6 
macrophages, C. burnetii replication could be assessed in Rip3-/-Casp8-/- BMDMs, which 
are unable to undergo either extrinsic apoptosis or necroptosis (Pasparakis and 
Vandenabeele, 2015). 
    We also examined ROS and RNS as possible effector mechanisms of TNF-mediated 
control of C. burnetii infection in B6 macrophages. ROS and RNS have previously been 
shown to be induced by C. burnetii infection in some studies and not induced in others 
(Akporiaye et al., 1990; Brennan et al., 2004; Dellacasagrande et al., 2000; Zamboni and 
Rabinovitch, 2003). In the presence of exogenous TNF and IFNγ, ROS and RNS were 
implicated in the restriction of C. burnetii replication (Zamboni and Rabinovitch, 2003). 
However, it has also been shown that C. burnetii secretes an acid phosphatase, which 
may play a role in resistance to ROS (Hill and Samuel, 2011). Whether endogenously 
produced TNF induces production of ROS and RNS in C57BL/6 macrophages during C. 
burnetii infection has not been shown. Moreover, whether RNS and ROS mediate 
restriction of C. burnetii in macrophages in the absence of exogenously added 
recombinant cytokines has not been extensively studied.  
   We found Nos2 mRNA and the iNOS byproduct NO2- were induced in B6 
macrophages in response to C. burnetii infection, and we observed a significant 
reduction in the induction of both Nos2 and RNS in Tnf-/- macrophages. These findings 
indicate that C. burnetii does induce a functional iNOS protein that is partially dependent 
on the production of endogenous TNF. Tnf-/- macrophages still produced a low level of 
iNOS and NO2-, which suggests that another pathway, potentially TLR signaling itself, 
can lead to the production of RNS during C. burnetii infection. To determine if iNOS 
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plays a role in restriction of C. burnetii, measuring bacterial growth in iNOS-/- BMDMs or 
growth in the presence of iNOS inhibitors, such as S-methylisothiourea sulfate and L-
N(6)-(1-iminoethyl)-lysine (L-NIL) are necessary.  
   We also demonstrated C. burnetii infection results in production of measurable levels 
of whole cell ROS by B6 macrophages. Furthermore, our preliminary results indicate that 
gp91phox, a component of NADPH oxidase, plays a role in restricting C. burnetii growth 
in B6 macrophages. These data indicate that ROS is induced during infection and 
mediate a role in growth restriction, but do not show that this ROS is the direct product of 
TNF signaling. Since ROS can be induced by a variety of stimuli and pathways, future 
studies should analyze ROS production in Tnf-/- BMDMs to determine if induction is 
dependent on this cytokine or via another mechanism. 
    Interferon-inducible guanylate-binding proteins (GBPs) have recently been implicated 
in the cell-intrinsic control of a variety of pathogens and have been shown to be induced 
by TNF (Pilla et al., 2014; Vestal and Jeyaratnam, 2011; Yamamoto et al., 2012). Their 
role in host control of C. burnetii infection has not been assessed. Moreover, it is not 
known whether TNF alone, in the absence of interferon, is sufficient to induce expression 
of many mGBPs. Here we demonstrated that either TNF alone or C. burnetii infection 
are sufficient to induce expression of the mRNAs encoding mGBP-1 and mGBP-2, which 
have been shown to exhibit antiviral and antiparasitic responses by delivery of 
antimicrobial cargo to the autophagosome (Degrandi et al., 2013; Vestal and 
Jeyaratnam, 2011). We further tested if mGBP-1,-2,-3,-5, and -7 play a role in growth 
restriction using mice missing these GBPs, which are encoded on chromosome 3 
(Yamamoto et al., 2012). We found that these five murine GBPs were not required to 
restrict C. burnetii replication. Induction of mouse GBPs present on chromosome 5, 
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mGBP-6,-8,-9,-10,-11 (mGBP-4 is non-functioning in C57BL/6 macrophages) and 
whether these GBPs are localized to the C. burnetii vacuole should also be tested. If C. 
burnetii does induce these GBPs, then experiments examining the roles of these GBPs 
during C. burnetii infection using siRNA-mediated gene silencing could shed light on 
their role in restricting bacterial replication. 
     In conclusion, we were able to build upon our previous findings that TLR detection of 
C. burnetii infection is a major mechanism of control in C57BL/6 macrophages. 
Furthermore, we were able to implicate TNF produced as a consequence of TLR 
detection as a major player in this restriction. In our analysis of possible TNF-mediated 
restriction mechanisms, our preliminary data indicate that the NADPH oxidase plays a 
role in the inhibition of C. burnetii replication in C57BL/6 macrophages.  
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Figure 3.1 Endogenous TNF restricts intracellular growth of C. burnetii. (A) 
C57BL/6 and Tnf-/- BMDMs were infected with WT C. burnetii NMII expressing mCherry 
at MOI=100. C. burnetii GEs were determined by qPCR on days 1, 3, 5, and 7 post-
infection. Graphs show the fold change in GEs relative to day 1 ± SEM of triplicate wells. 
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Representative of three independent experiments. (B) 10ng/mL rTNF or supernatants 
from C57BL/6 BMDMs infected with WT C. burnetii NMII for 24 hours were added to WT 
C. burnetii-infected Tnf-/-  and Tlr2-/- BMDMs on days 1 and 5 post-infection. C. burnetii 
GEs were measured by qPCR and the fold increase in GEs on day 7 post-infection was 
determined relative to the GEs on Day 1. Graphs show the fold change in GEs relative to 
day 1 ± SEM of triplicate wells. Representative of two independent experiments. (C) B6 
or Tnf-/- BMDMs were infected with mCherry-expressing WT C. burnetii or 10ng/mL rTNF 
was added to mCherry-expressing WT C. burnetii-infected Tnf-/- BMDMs on days 1 and 5 
post-infection. On day 7 post-infection, cells were fixed, stained with DAPI, and imaged 
by fluorescence microscopy. The number of mCherry-expressing C. burnetii-containing 
vacuoles was determined and calculated as a percentage of total cell number. Graphs 
show mean percentage of cells containing C. burnetii vacuoles ± SEM of triplicate 
coverslips. At least 300 cells were counted per coverslip. (D) Representative images 
(40x) of mCherry-expressing C. burnetii-containing vacuoles in infected BMDMs treated 
as in (C). Scale bars represent 25µM. Representative of two independent experiments. 
(E) 10ng/mL rTNF or supernatants from B6 BMDMs infected with WT C. burnetii NMII for 
24 hours were added to WT C. burnetii-infected Tlr2-/- BMDMs on days 1 and 5 post-
infection. C. burnetii GEs were measured by qPCR and the fold increase in GEs on day 
7 post-infection was determined relative to the GEs on Day 1. Graphs show the fold 
change in GEs relative to day 1 ± SEM of triplicate wells. Representative of two 
independent experiments. *p<0.05, **p<0.01, ***p<0.001, ns=no significance. 
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Figure 3.2 C. burnetii does not induce apoptosis in B6 macrophages. (A) and (B) 
C57BL/6 BMDMs were infected with WT C. burnetii NMII expressing mCherry at 
MOI=100 for 24 hours or treated with 1000 μM staurosporine for 4 hours.  Post-infection, 
cells were fixed, stained with TUNEL (green) and DAPI (blue), and imaged by 
fluorescence microscopy. The number of TUNEL positive cells was determined and 
calculated as a percentage of total cell number. Graphs show mean percentage of 
TUNEL positive cells ± SEM of triplicate coverslips. At least 300 cells were counted per 
coverslip. (B) Representative images (20x) of TUNEL positive cells positive cells.  
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Figure 3.3 C. burnetii infection does induce iNOS mRNA and NO2- in a TNF 
dependent manner. C57BL/6 and Tnf-/- BMDMs were mock-infected, treated with E. coli 
LPS, 10 ng/mL mouse recombinant TNF, or infected with WT C. burnetii NMII at MOI= 
50 or 100. (A) 16 hours post infection, fold-induction of Nos2 mRNAs were measured via 
qRT-PCR. Graphs show the mean ± SEM of triplicate wells in a 48 well plate. 
Representative of two independent experiments.  (B) NO2- was measured in the 
supernatants 24 hours post infection. Graphs show the mean ± SEM of triplicate wells in 
a 96 well plate. Representative of two independent experiments. *p<0.05, **p<0.01. 
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Figure 3.4 C. burnetii infection induces whole cell ROS and ROS plays a role in 
restricting intracellular growth in B6 BMDMs. (A) C57BL/6 were mock-infected, 
treated with E. coli LPS for 6 hours, or infected with WT C. burnetii NMII at MOI= 100 for 
16 hours. Whole cell ROS was measured by flow cytometry. Representative of two 
independent experiments. *p<0.05, **p<0.01. (B) C57BL/6, gp91phox-/-, and Tnf-/- 
BMDMs were infected with WT C. burnetii NMII expressing mCherry at MOI=100. C. 
burnetii GEs were determined by qPCR on days 1, 3, 5, and 7 post-infection. Graphs 
show the fold change in GEs relative to day 1 ± SEM of triplicate wells. **p<0.01 and 
***p<0.001. 
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Figure 3.5 C. burnetii infection induces expression of mGBP-1 and mGBP-2, but 
GBPs 1, 2, 3, 5, and 7 do not play a role in restricting C. burnetii replication. (A) 
and (B) C57BL/6 BMDMs were mock-infected, 10 ng/mL recombinant mouse TNF, or 
infected with WT C. burnetii NMII at MOI= 50 or 100. 16 hours post infection, fold-
induction of mGBP-1 and mGBP-2 mRNAs were measured via qRT-PCR. Graphs show 
the mean ± SEM of triplicate wells in a 48 well plate. Representative of two independent 
experiments.  (C) C57BL/6, GBPchrm3-/- and Tnf-/- were infected with WT C. burnetii NMII 
expressing mCherry at MOI=100. C. burnetii GEs were determined by qPCR on days 1, 
3, 5, and 7 post-infection. Graphs show the fold change in GEs relative to day 1 ± SEM 
of triplicate wells. Graphs show the mean ± SEM of triplicate wells.  
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Figure 3.6.  Levels of internalized WT Coxiella burnetii are similar for different 
genotypes of bone marrow-derived macrophages at 24 hours post-infection. 24 
hours post-infection, the number of internalized WT C. burnetii NMII genomic equivalents 
(GEs) were measured by qPCR for (A) C57BL/6, Tlr2-/-, Tlr4-/-, and Tlr2-/-Tlr4-/- BMDMs 
presented in Figure 2.1C,   
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    In the studies described here, we sought to determine the innate immune response 
mounted by macrophages against C. burnetii burnetii, a poorly understood intracellular 
bacterium. The C. burnetii field has made great advances over the years. The advent of 
an axenic growth media and improved methods for genetic manipulation has given the 
scientific community new tools to better understand its pathogenesis. While the field has 
made considerable progress in understanding the cell biology of C. burnetii’s intracellular 
niche, the innate immune response to C. burnetii is poorly understood. This is in part due 
to wide variation in cell lines, animal models, and bacterial strains employed by different 
groups. 
     Our first goal was to establish a standardized system in C57BL/6 primary bone 
marrow-derived macrophages. This system has been used to study a variety of 
pathogens and due to the large number of available mice with select innate immune 
deficiencies, allowed us to cast a wide net in the innate immune pathways we analyzed. 
Furthermore, in the context of the C. burnetii Nine Mile phase II strain, this system offers 
a unique opportunity to study cell-intrinsic mechanism of bacterial control as C57BL/6 
macrophages are naturally able to restrict C. burnetii NMII infection. 
     With this infection system, in our first aim we sought to answer two questions: [1] 
which innate immune responses are activated in vitro; and [2] what role does Type IV 
secretion system-mediated translocation of bacterial products play in triggering these 
innate immune responses. We hypothesized that since C. burnetii is able to survive 
inside cells over a long period of time and delays neutrophil recruitment in the lung 
(Elliott et al., 2013; van Schaik et al., 2013), it evolved strategies to evade innate 
immune detection, potentially through the injection of T4SS effector proteins. Our survey 
of three classical innate immune pathways allowed us to implicate TLR-mediated TNF 
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production as a major player in the cell-intrinsic control of C. burnetii in C57BL/6 
macrophages. 
 
TLR detection is more critical than cytosolic detection for the induction of pro-
inflammatory cytokines and the cell-intrinsic control of Coxiella 
    To address our first aim, we assessed C. burnetii’s ability to activate various innate 
immune pathways in C57BL/6 BMDMs. To further test our hypothesis that C. burnetii 
has evolved strategies to subvert innate immune detection we investigated the role of its 
T4SS in activating these pathways. In particular, we examined cell surface and cytosolic 
immune detection and induction of pro-inflammatory cytokines, the activation of the 
inflammasome, and the induction of Type I interferon response. We wanted to both 
determine C. burnetii’s ability to activate these pathways and test whether they mediated 
cell-intrinsic control of bacterial replication (Zamboni, 2004). Furthermore, to determine 
the role of the T4SS in mediating these responses, we utilized an isogenic NMII strain 
containing a transposon insertion in the gene icmL (Carey et al., 2011). 
     In these studies, we built upon past work that showed an important role for TLR2 in 
mediating production of pro-inflammatory cytokines and an inconclusive role for TLR4 
(Barry et al., 2012; Shannon et al., 2005; Zamboni et al., 2004). We confirmed previous 
findings that TLR2 plays a major role in the production of pro-inflammatory cytokines 
TNF and IL-6, but also found a role for TLR4 in the induction of these cytokines. Upon 
further analysis of the downstream adaptors MyD88 and Trif, we found a role for both 
MyD88 and Trif in both the production of TNF and IL-6 and the inhibition of C. burnetii 
replication. Since Trif is classically thought to signal only through TLR4 and TLR3 (Akira, 
2003), with TLR3 largely associated with recognition of viral infection, this further 
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suggests TLR4 responds to C. burnetii infection. We wanted to next determine whether 
C. burnetii’s LPS was the ligand responsible for TLR4-dependent responses. Past 
studies have shown that purified C. burnetii LPS is not stimulatory for TLR4 and instead 
acts as a TLR4 antagonist (Zamboni et al., 2004). We confirmed this was the case in our 
system. TLR4 can also recognize host danger-associated molecular patterns (DAMPs) 
that are released upon infection such as HMGB-1 (Pasparakis and Vandenabeele, 
2015), but these are unlikely since we observe no measurable cell death 24 hours post 
infection. One possibility is that TLR4 recognition of C. burnetii LPS requires 
simultaneous detection of other bacterial PAMPs by other TLRs.  
     Since the T4SS is required for C. burnetii growth within host cells (Beare et al., 2011), 
it is possible that restrictive C57BL/6 macrophages are somehow not permissive for 
translocation of T4SS substrates, and thus cytosolic immune sensors would not be 
triggered during C. burnetii infection in this cell type. We confirmed via a single cell 
assay that the C. burnetii T4SS does inject effectors into C57BL/6 macrophages, 
allowing us to further investigate whether cytosolic immune detection occurs. To 
examine this, we first compared the ability of WT NMII and icmL::Tn NMII, lacking a 
functional T4SS, to induce proinflammatory cytokines. The L. pneumophila T4SS has 
been shown to trigger an enhanced cytokine response, presumably due to its 
translocation of multiple bacterial ligands that are detected by cytosolic sensors that 
promote cytokine expression. We interestingly found no increase in TNF or IL-6 
production by B6 macrophages infected with WT bacteria compared to the icmL::Tn 
mutant, and our data suggest that there is a slight decrease in TNF and IL-6 production 
in response to WT bacteria. This suggests that C. burnetii either does not secrete 
immunostimulatory ligands or that it inhibits cytokine production via one or more T4SS 
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effectors. Future studies will determine if C. burnetii T4SS effectors are actively blocking 
TNF and IL-6 production. Since C. burnetii has undergone genome reduction over its 
evolutionary history, it is also possible that it has altered or eliminated genes encoding 
immunostimulatory ligands. 
     To further test whether there is cytosolic immune detection of C. burnetii, we 
investigated C. burnetii’s ability to activate the inflammasome. To test this, we used a 
variety of readouts for inflammasome activation that have been employed to study the 
inflammasome in the context of other bacterial pathogens, such as L. pneumophila 
(Casson and Shin, 2013). We surprisingly found no activation of the inflammasome 
following C. burnetii infection of B6 macrophages, even in cells that had been primed 
with LPS to ensure that all the necessary inflammasome components were highly 
upregulated. This phenomenon could again be the result of C. burnetii not encoding 
inflammasome-activating ligands or actively inhibiting inflammasome activation via T4SS 
effectors, as seen with Yersinia species, which utilize the T3SS effectors YopK and 
YopM to inhibit caspase-1 activation (Brodsky et al., 2010; LaRock and Cookson, 2012). 
Future studies that examine whether C. burnetii can inhibit inflammasome activation 
downstream of external stimuli, similar to those used to determine that C. burnetii inhibits 
intrinisic apoptosis, would offer further insight into C. burnetii’s subversion of the 
inflammasome. 
     Type I interferon (IFN) was the final arm of the innate immune response we studied. 
Type I IFNs are thought to primarily play a role in the immune response to viruses and 
have the potential to be induced by immune sensors both at the cell surface and within 
the cytosol (Müller et al., 1994). Recently, they been shown to play a role in some 
bacterial infections (Lippmann et al., 2011; Monroe et al., 2010). Studies have shown 
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type I IFNs can restrict Legionella replication (Coers et al., 2007; Schiavoni et al., 2004), 
while other studies have shown that they can promote bacterial infection, as is the case 
for M. tuberculosis (Manzanillo et al., 2012). Whether type I IFNs play a role in restricting 
C. burnetii infection has not been studied. Despite a role for Trif, which induces type I 
IFN production downstream of IRF-3 phosphorylation (Akira, 2003), in both cytokine 
production and bacterial restriction, we did not observe robust induction of Type I 
interferon, nor did we observe a role for type I IFNs in the restriction of C. burnetii 
replication in B6 macrophages. 
     In sum, we determined that TLR detection plays a dominant role in the production of 
proinflammatory cytokines during C. burnetii infection. Although we found that the T4SS 
is functional and translocates bacterial products into B6 macrophages, our data rule out 
cytosolic immune activation of pro-inflammatory cytokines and the inflammasome as 
major players mediating the restriction of C. burnetii growth in B6 macrophages. We 
further ruled out the type I IFN response as being induced or playing a role in cell-
intrinsic restriction during C. burnetii infection. It again is possible that C. burnetii inhibits 
type I IFN induction through the activity of its T4SS effectors or does not possess or 
expose immunostimulatory ligands that robustly activate the sensors leading to type I 
IFN induction. However, since Trif plays an important role in TNF and IL-6 induction 
during C. burnetii infection, we would have anticipated that Trif signaling would have also 
led to type I IFN induction. In future studies, it would be of interest to determine if IRF3 is 
phosphorylated. If IRF3 is activated, then it is possible that C. burnetii may target the 
transcription or translation of type I IFNs.  
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TNF is a mechanism by which B6 macrophages inhibit Coxiella burnetii 
replication. 
     We expanded upon our initial studies, which implicated TLRs as the major sensors 
responsible for production of cytokines during C. burnetii infection and cell-intrinsic 
control of bacterial replication. We hypothesized that TLR signaling induces a soluble 
factor that then activates an antimicrobial response. We found TNF, a pleiotropic 
cytokine that activates many cell-intrinsic and cell-extrinsic immune pathways, plays a 
major role in C. burnetii restriction. TNF has been implicated in the restriction of a variety 
of pathogens through the induction of cell death pathways, the activation of an 
antimicrobial response within infected cells (RNS, ROS, antimicrobial peptides, etc.), the 
induction of autophagy, alterations in iron acquisition, and the induction of guanylate 
binding proteins (Bekker et al., 2001; Johnson and Wessling-Resnick, 2012; Pasparakis 
and Vandenabeele, 2015; Yamamoto et al., 2012; Yuk et al., 2012). 
     We narrowed our studies towards examining three possible mechanisms: apoptotic 
and necroptotic cell death, production of RNS and ROS, and induction of guanylate 
binding proteins. Autophagy is a possible mechanism of control; however, there is strong 
evidence that C. burnetii actively engages the autophagy pathway to promote its 
intracellular growth. Whether there is a role for host-driven modulation of iron levels in 
restricting C. burnetii infection is unclear, although a study suggested that C. burnetii 
actually replicated better within macrophage lines treated with an iron chelator compared 
to iron-replate macrophages (Briggs et al., 2008). It is possible that TNF-mediated 
alterations in phagocytic iron levels could still play a role in limiting C. burnetii replication. 
    We found C. burnetii does not induce cell death at measurable levels in C57BL/6 
macrophages using both population-based and single cell-based assays, suggesting 
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that apoptosis and necroptosis are likely not major TNF-mediated control mechanisms in 
vitro. One possible caveat is that we did not use a single cell assay to detect 
necroptosis, so it is still possible that this form of cell death is occurring, and it is possible 
that necroptosis could mediate restriction of C. burnetii by occurring at an earlier time 
point in a small number of infected cells. However, since we observed the formation of 
large C. burnetii-containing vacuoles in a relatively large percentage of cells (~10-20%) 
in infected permissive macrophages lacking TLR2 or TNF, that would suggest that death 
of a small number of infected cells would not be sufficient to limit C. burnetii infection in 
our model. Since C. burnetii has been shown to inhibit intrinsic apoptosis through its 
T4SS, it is also possible that it uses bacterial effectors to inhibit extrinsic apoptosis and 
necroptosis. Studies where these pathways are artificially induced in C. burnetii-infected 
cells could aid in determining whether C. burnetii actively inhibits these cell death 
pathways and shed light on how C. burnetii is able to grow inside macrophages while 
inducing minimal cell death. 
    We did find that there was induction of both RNS and ROS in response to C. burnetii 
infection, and we further found RNS induction to be dependent on TNF. Future studies 
will determine whether ROS production is TNF-dependent. Our preliminary data also 
indicate that the NADPH oxidase, a major generator of ROS, plays a role in the 
restriction of C. burnetii replication in B6 macrophages, and future studies will determine 
whether RNS play a role in restricting C. burnetii replication in B6 macrophages. Studies 
with S. Typhimurium, which has a relatively short replication time within the host cell, 
showed ROS to be a major mediator of bacterial growth restriction (Mantena et al., 
2008), while studies with M. tubercuolosis, which has a longer replication time within the 
host cell, showed RNS to be a major restriction factor (Davis et al., 2007). Since C. 
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burnetii has a long replication time, it would be interesting to know if RNS plays a role in 
restriction at a later time point than ROS. These two pathways could target C. burnetii 
replication at different stages of its prolonged life cycle inside the cell. 
     We found that treatment of macrophages with TNF alone or C. burnetii infection of 
macrophages is capable of inducing two GBPs, GBP-1 and GBP-2, but did not find any 
evidence of a role for these or other GBPs in mediating growth restriction, as we did not 
observe increased C. burnetii replication when five of the eleven murine GBPs (GBP-1, -
2, -3, -5, and -7) were absent. Further studies are necessary to implicate or definitively 
rule out GBPs as a potential effector mechanism underlying TNF-mediated bacterial 
restriction. Furthermore, since the C. burnetii vacuole can expand to occupy the majority 
of the cell cytosol and recruits membranes from a variety of sources, it would be 
interesting to know if any of the GBPs localize to the C. burnetii-containing vacuole.  
 
Future Directions 
Innate immune detection of Coxiella burnetii by cell surface and cytosolic sensors 
    Our findings open doors for many future studies aimed at examining the innate 
immune response to C. burnetii and its ability to evade innate immune detection.  In 
continuing our first aim, short-term future directions should: define the exact signaling 
cascades activated by MyD88 and Trif signaling, determine whether TLR4 (or another 
TLR) is responsible for Trif-mediated signaling, and determine whether there is T4SS-
mediated inhibition of these pathways. Long-term future directions should include: 
analysis of the activation of these innate immune pathways in human cell lines and 
primary human cells and in vivo studies in mice. 
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     Further defining which specific downstream signaling pathways are activated (NF-κB, 
MAPKs, IRFs) would offer a more complete picture of how TLRs and adaptors induce 
signaling cascades that lead to the expression of pro-inflammatory cytokines and other 
immune proteins. Since pro-inflammatory cytokine production can occur downstream of 
both NF-κB and MAPK activation, a complete picture of C. burnetii’s activation of these 
pathways would be useful in determining its ability to manipulate or evade some of these 
innate immune responses. 
     We have not yet directly demonstrated that TLR4 mediates Trif signaling during C. 
burnetii infection. Furthermore, we found that purified C. burnetii LPS does not stimulate 
cytokine production in B6 macrophages, making it unclear how C. burnetii infection is 
triggering TLR4 signaling. Studies in cell lines ectopically expressing TLR4 or both TLR2 
and TLR4 could shed light on determining whether TLR4 detects and signals through Trif 
in the context of the whole bacterium and whether TLR4 is sufficient to mediate 
responses to C. burnetii. It is also possible that TLR4-mediated detection of C. burnetii 
infection may somehow require an initial signal emanating from TLR2 detection. Thus, 
these studies should also include cell lines expressing both TLR2 and TLR4 to test this 
latter possibility. 
     Many intracellular bacteria utilize their secretion systems to translocate effector 
proteins that directly inhibit the activation of innate immune responses (Brodsky and 
Medzhitov, 2009). Since C. burnetii injects over 100 effector proteins, it is likely that 
some of these effectors target innate immune signaling pathways. Further studies could 
provide insight into whether there is T4SS-mediated inhibition of immune signaling. 
Comparing immune responses following artificial induction of immune pathways in 
infected cells versus uninfected cells would be one way to determine whether the T4SS 
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mediates immune inhibition, analogous to past studies showing that artificially induced 
intrinisic apoptosis is inhibited in a T4SS-dependent manner. For example, studies 
comparing responses to WT vs icmL::Tn C. burnetii NMII strains following induction of 
inflammasome activation with exogenous addition of ATP or induction of type I interferon 
with poly(I:C) would be useful. If cells infected with WT C. burnetii display less innate 
immune activation, then this would suggest that the T4SS translocates effectors that 
dampen immune signaling.  
     In the long-term, studies should examine innate immune responses to C. burnetii 
infection in human and murine macrophages. Humans and mice have evolved many 
divergent innate immune pathways. While our studies in mouse macrophages show the 
inflammasome is not activated and type I interferons are not induced during C. burnetii 
infection, it is possible that human immune sensors are able to respond to C. burnetii 
infection. One study with primary human alveolar macrophages showed that C. burnetii 
infection induces the release of IL-1β, but did not implicate inflammasome activation in 
this system. Further studies in THP-1 cells and human primary macrophages would 
provide important insight into innate immune detection and control of C. burnetii.  
     Our studies only examined activation of innate immune pathways in macrophages. It 
is possible that different innate immune pathways are activated in other cells that would 
be expected to come into contact with C. burnetii in the lungs of an infected host, such 
as neutrophils, dendritic cells, and airway epithelial cells. Future studies examining the 
innate immune responses of these different cell types to C. burnetii would provide 
important insight into this question. Furthermore, future studies in mice using an 
intranasal model of infection could determine if these pathways are activated in systemic 
infection. 
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TNF as an Inhibitor of Coxiella burnetii Intracellular Replication 
How TNF signaling restricts the intracellular replication of C. burnetii within host cells is 
unclear. To provide additional insight into the underlying mechanism, short-term future 
directions, building upon our initial findings, should: further determine whether RNS and 
ROS are responsible for the ability of TNF to mediate restriction and further analyze 
whether the mGBPs play a role in restricting C. burnetii infection,. Long term future 
directions should include examining the role of TNF in controlling C. burnetii growth and 
dissemination during in vivo infection. 
     TNF signaling can lead to cell death in other systems, but our data suggested that 
cell death was not robustly triggered during C. burnetii infection of macrophages. 
Examining C. burnetii replication in WT B6 macrophages compared to macrophages 
deficient in RIP3, which is required for necroptosis, or both RIP3 and caspase-8, which 
eliminates both extrinsic apoptosis and necroptosis, would provide important insight into 
whether cell death mediates TNF-dependent restriction of C. burnetii replication. Our 
data indicate that iNOS and the production of RNS are induced during C. burnetii 
infection in a TNF-dependent manner. Future experiments using RNS inhibitors or iNOS-
deficient macrophages will aid in determining whether iNOS and RNS are involved in 
restricting C. burnetii replication. While we found that whole cell ROS was induced in 
response to C. burnetii infection, and our preliminary data suggest that the NADPH 
oxidase plays a role in restriction of C. burnetii, studies of ROS production in Tnf-/- 
macrophages are necessary to link ROS-mediated restriction to TNF. It is also possible 
that TNF signaling somehow inhibits efficient T4SS translocation as a means to restrict 
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C. burnetii replication. Experiments that measure the magnitude of injection in WT and 
TNF-deficient macrophages using the BlaM translocation assay could help answer this. 
     Future studies should also examine whether GBPs are possible mediators of C. 
burnetii restriction within B6 macrophages, as our preliminary data indicate that at least 
two GBPs, mGBP-1 and mGBP-2, are transcriptionally induced during C. burnetii 
infection. GBPs have been implicated in restricting the intracellular replication of a 
variety of vacuolar pathogens, and further analysis of their expression and localization 
patterns and performing a targeted siRNA screen of the mGBPs could offer insight into 
their role during C. burnetii infection. While they have classically been thought to play a 
role in restriction of pathogens, it is also possible that their induction and recruitment to 
the vacuole may benefit C. burnetii and aid in its replication. C. burnetii is thought to 
engage with the autophagy pathway to promote its intracellular replication so it would be 
of interest to know if GBPs also fulfill a similar role. 
     It would also be of interest to determine which cells in the infected population are 
producing TNF. L. pneumophila and S. flexneri employ effector proteins that inhibit the 
production of pro-inflammatory cytokines by targeting host translational elongation 
factors and p38 and ERK MAPK signaling, respectively (Reiterer et al., 2011; Rolando 
and Buchrieser, 2014). In the case of L. pneumophila, it was recently shown using single 
cell assays that bystander cells are the primary producers of TNF and other cytokines 
(Copenhaver et al., 2015). Our studies thus far have relied largely on population-based 
assays, but single cell-based assays examining whether infected or uninfected cells 
produce cytokines would provide insight. Using the CCF4-AM/BlaM system in 
conjunction with mCherry-expressing C. burnetii would help divide the cells into 
uninfected, infected but uninjected, and T4SS-injected cells. A significant reduction in 
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cytokine-positive cells in the T4SS-injected population compared to uninjected cells 
would suggest that C. burnetii T4SS activity actively blocks production of 
proinflammatory cytokines.  
     Our studies focused solely on cell-intrinsic pathways of TNF restriction within 
macrophages during in vitro infection with the Nine Mile II strain, which is attenuated for 
virulence. It would also be of interest to determine the role for TNF in control of systemic 
infection with virulent C. burnetii strains. Intranasal infection of WT and TNF-deficient 
mice and measurement of bacterial burdens would offer a broader view of TNF as a 
control mechanism during in vivo infection. Since granulomas are thought to be 
important in the restriction of C. burnetii and may be linked to the formation of chronic 
infection, assays for granuloma formation in WT and TNF-deficient infected animals 
would be of great interest. 
     Finally, it is important to determine whether C. burnetii T4SS effectors participate in 
innate immune subversion. C. burnetii encodes over 100 effector proteins, many of 
which contain eukaryotic protein domains and unique localization patterns (Carey et al., 
2011). Our discovery of various immune pathways that are not robustly activated during 
C. burnetii infection, such as inflammasome activation or the induction of type I IFNs, 
would offer possible phenotypes amenable to screening for T4SS effectors that inhibit 
these innate immune responses using gain-of-function or loss-of-function genetic 
approaches. Furthermore, advances in the field have allowed for the generation of 
transposon mutant libraries of effector proteins and it is now possible to test the roles of 
these effectors in inhibiting innate immune pathways in a similar fashion to the types of 
studies that have been performed in more genetically malleable bacteria. 
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Concluding Remarks 
     Innate immune recognition is a crucial first step in detecting and preventing microbial 
infection. Eukaryotic organisms have evolved specialized immune sensors that 
recognize a broad array of pathogen-associated molecular patterns (PAMPs). Detection 
of pathogens via these sensors activates cell-intrinsic and -extrinsic immune pathways to 
clear invaders. Many pathogens have evolved strategies to evade detection from these 
sensors in order to overcome innate immune barriers to infection. These evasion 
techniques can involve alterations in their PAMPs to become less immunostimulatory or 
the production of virulence factors that actively block key components of innate immune 
pathways. Intracellular bacteria pose a unique set of challenges for host organisms. 
They are shielded from circulating immune cells and molecules and also have evolved 
mechanisms to hijack host cells in order to form their replicative niche and evade 
intracellular detection. Much remains to be understood about how the innate immune 
system detects and controls the intracellular replication of this unique class of 
pathogens. 
     Coxiella burnetii is an intracellular bacterium that lives and grows in the lysosome, the 
harshest environment found within a cell. This bacterium can replicate in cells 
unchecked for days and can establish acute and chronic infections in humans. Unlike 
other bacteria, C. burnetii does not seem to induce robust innate immune activation. In 
these studies, we sought to define the innate immune pathways that C. burnetii does and 
does not activate in mouse macrophages, and understand the roles of these pathways in 
restricting C. burnetii infection. To address these questions, we chose to use restrictive 
B6 macrophages, which control C. burnetii replication, as a model for understanding the 
host factors involved in successful restriction of C. burnetii replication. We found that C. 
	  
	   117 
burnetii infection does not robustly activate cytosolic immune sensors, the 
inflammasome, or the Type I interferon response. Instead, we found induction of pro-
inflammatory cytokines and intracellular restriction of C. burnetii replication to be largely 
dependent on TLR signaling. The lack of a robust cytosolic immune response is 
remarkable because C. burnetii is capable of translocating bacterial effectors into the 
host cell cytosol of B6 macrophages. How it is able to accomplish effector translocation 
into host cells, while evading the slew of cytosolic immune sensors present within these 
cells, remains unknown, but it is likely C. burnetii has many strategies to overcome 
innate immune detection, potentially through its T4SS effectors. 
     Our findings also implicated endogenously produced TNF as a major mediator of cell-
intrinsic immunity against C. burnetii within B6 macrophages. TNF is a broad-acting 
cytokine with a wide variety of downstream immune responses. We sought to determine 
the mechanism of TNF-mediated cell-intrinsic control by testing the role of several 
putative effector pathways known to be TNF-regulated in other systems. Our findings 
indicate that cell death likely does not play a major role in TNF-mediated restriction. 
Furthermore, our preliminary data suggest that several of the murine guanylate binding 
proteins are not required for TNF-mediated restriction. In addition, we further found that 
C. burnetii induces ROS and RNS, and our preliminary data suggest that the NADPH 
oxidase plays a role in cell-intrinsic control. Future studies are necessary to determine 
whether these pathways mediate the TNF-dependent restriction of C. burnetii infection, 
but our model system using C57BL/6-background macrophages deficient in select 
immune genes will allow us to test the role of these pathways in controlling C. burnetii 
infection. 
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     Together, our studies suggest that C. burnetii does not robustly activate many innate 
immune pathways, but also offer new insight into possible mechanisms by which host 
cells are able to overcome C. burnetii’s subversion and restrict intracellular replication. 
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Figure 4.1. Proposed Mechanism of TLR-mediated control of C. burnetii 
replication in C57BL/6 macrophages.  Restriction of C. burnetii replication in C57BL/6 
macrophages is dependent on TLR-mediated induction and secretion of TNF. TLR2 and 
TLR4 recognize C. burnetii and signal through both adaptors MyD88 and Trif to induce 
the production of TNF. TNF then binds to infected cells to induce the production of 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) which inhibit 
intracellular replication of C. burnetii. Restriction of replication in C56BL/6 is independent 
of cytosolic innate immune sensors. 
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